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SUMMARY : 
A deficiency in pejvakin, a protein of unknown function, causes a strikingly 
heterogeneous form of human deafness. Pejvakin-deficient (Pjvk-/-) mice also exhibit 
variable auditory phenotypes. Correlation between their hearing thresholds and the 
number of pups per cage suggest a possible harmful effect of pup vocalizations. Direct 
sound or electrical stimulation show that the cochlear sensory hair cells and auditory 
pathway neurons of Pjvk-/- mice and patients are exceptionally vulnerable to sound. 
Subcellular analysis revealed that pejvakin is associated with peroxisomes, and 
required for their oxidative stress-induced proliferation. Pjvk-/- cochleas display 
features of marked oxidative stress and impaired anti-oxidant defenses, and 
peroxisomes in Pjvk-/- hair cells show structural abnormalities after the onset of 
hearing. Noise exposure rapidly upregulates Pjvk cochlear transcription in wild-type 
mice, and triggers peroxisome proliferation in hair cells and primary auditory 
neurons. Our results reveal that the anti-oxidant activity of peroxisomes protects the 
auditory system against noise-induced damage. 
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INTRODUCTION 
Mutations of PJVK, which encodes pejvakin, a protein of unknown function present 
only in vertebrates, cause the DFNB59 recessive form of sensorineural hearing impairment. 
In the first patients described (Delmaghani et al., 2006), the impairment was restricted to 
neurons of the auditory pathway, with auditory brainstem responses (ABRs) displaying 
abnormally decreased wave amplitudes and increased inter-wave latencies (Starr and Rance, 
2015). ABRs monitor the electrical response of auditory pathways to brief sound stimuli, 
from the primary auditory neurons synapsing with the sensory cells of the cochlea, the inner 
hair cells (IHCs), to the colliculus in the midbrain (Møller & Jannetta, 1983). However, 
some DFNB59 patients were found to have a cochlear dysfunction, as shown by an absence 
of the otoacoustic emissions (OAEs) that are produced by the outer hair cells (OHCs), 
frequency-tuned cells endowed with electromotility that mechanically amplify the sound-
stimulation of neighboring IHCs (Ashmore, 2008). These patients had truncating mutations 
of PJVK, whereas the previously identified patients, with extant OAEs, had missense 
mutations (p.T54I or p.R183W) (Ebermann et al., 2007; Schwander et al., 2007; Borck et 
al., 2011). However, the identification of patients also carrying the p.R183W missense 
mutation but lacking OAEs (Collin et al., 2007) refuted any straightforward connection 
between the nature of the PJVK mutation and the hearing phenotype. The severity of 
deafness in DFNB59 patients varies from moderate to profound, and may even be 
progressive in some patients, suggesting that extrinsic factors may influence the hearing 
phenotype. 
We investigated the role of pejvakin, with the aim of determining the origin of the 
phenotypic variability of the DFNB59 form of deafness. Our study of Pjvk knockout mouse 
models and of patients revealed an unprecedented hypervulnerability of auditory hair cells 
and neurons to sound-exposure, accounting for phenotypic variability. We found that 
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pejvakin is a peroxisome-associated protein involved in the oxidative stress-induced 
proliferation of this organelle. Pejvakin-deficient mice revealed the key role of peroxisomes 
in the redox homeostasis of the auditory system and in the protection against noise-induced 
hearing loss. 
 
RESULTS 
Heterogeneity in the hearing sensitivity of Pjvk-/- mice 
We generated pejvakin-null (Pjvk-/-) mice carrying a deletion of Pjvk exon 2 resulting 
in a frameshift at codon position 71 (p.Gly71fs*9) (Figure S1 and see Extended 
Experimental Procedures). ABR thresholds recorded on postnatal day 30 (P30) Pjvk-/- mice 
(n = 48), ranged from 35 to 110 dB SPL (Sound Pressure Level) at 10 kHz but never 
exceeded 30 dB SPL in their Pjvk+/+ littermates (n = 26) (Figure 1A). This broad range of 
hearing sensitivity in Pjvk-/- mice, from near-normal hearing to almost complete deafness, 
extended across the whole frequency spectrum. The thresholds of distortion-product OAEs 
(DPOAEs) at 10 kHz (i.e. the minimum stimulus required for DPOAEs production by 
OHCs) also fell within an abnormally large range of values, from 30 to 75 dB SPL, in 28 
Pjvk-/- mice, indicating an OHC dysfunction, and DPOAEs were undetectable in another 20 
Pjvk-/- mice, suggesting a complete OHC defect (Figure 1B). The absence of pejvakin in 
mice thus results in a puzzlingly large degree of hearing phenotype variability.  
 
Hypervulnerability to the natural acoustic environment in Pjvk-/- mice 
We investigated the variability of Pjvk-/- auditory phenotypes, by first determining 
the ABR thresholds of Pjvk-/- littermates from different crosses. Large differences were 
observed between crosses, with much lesser differences between the Pjvk-/- littermates of 
individual crosses. Litters with larger numbers of pups (6 to 12) had higher ABR thresholds, 
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suggesting that the natural acoustic environment, with the calls of larger numbers of pups, 
might be deleterious in Pjvk-/- mice. Pups are vocally very active from birth to about P20. 
We manipulated the level of exposure to pup calls by randomly splitting large litters of Pjvk-
/- pups into groups of 2, 4, 6 and 10 pups per cage, with foster mothers, before P10, i.e. 
several days before hearing onset. The ABR thresholds at P21 were significantly correlated 
with the number of pups raised together (p < 0.001, r2 = 0.51) (Figure 1C). 
We then evaluated the effect on hearing of a controlled sound-stimulation, by 
presenting 1000 tone bursts at 10 kHz, 105 dB SPL (2-ms plateau stimulations separated by 
60-ms intervals of silence), energetically equivalent to a 3-minute stay in the natural 
environment of a 12-pup litter, while monitoring the ABRs during sound-exposure. These 
conditions are referred to hereafter as "controlled sound-exposure". We probed the effect of 
sound exposure by ABR tests which, limited to 50 repetitions of tone bursts, did not 
influence the hearing thresholds of Pjvk-/- mice. In a sample of P30 Pjvk-/- mice with initial 
ABR threshold elevation (below 35 dB SPL), controlled sound-exposure affected ABR 
thresholds in the 12-20 kHz frequency interval (corresponding to the cochlear zones where 
hair-cell stimulation was strongest), with an immediate increase of 21.7 ± 10.3 dB (n = 8; p 
< 0.001), not observed in Pjvk+/+ mice (2.2 ± 2.4 dB, n = 12; p = 0.3) (Figure 1D). Pjvk-/- 
mice transferred to a silent environment after exposure displayed a further increase of 33.7 ± 
16.0 dB (n = 8) two days after exposure. The threshold shift decreased to 23.7 ± 18.0 dB at 
seven days, and disappeared entirely by 14 days. When exposed mice were returned to the 
box with their littermates, their ABR continued to increase, at a rate of 15 dB per week. 
Pejvakin deficiency thus results in particularly high levels of vulnerability to low levels of 
acoustic energy, and the increase in ABR thresholds is reversible but only slowly and in a 
quiet environment.  
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Hair cells and auditory pathway neurons are affected by pejvakin deficiency  
To identify the cellular targets of the pejvakin deficiency, we specifically probed the 
function of auditory hair cells and neurons in Pjvk-/-, hair cell-conditional Pjvk knockout 
(Pjvkfl/flMyo15-cre+/-), and Pjvk+/+ mice, at the age of three weeks, before and after 
controlled sound-exposure or controlled electrical simulation. The responses of the IHCs to 
sound-induced vibrations amplified by OHCs trigger action potentials in the distal part of 
primary auditory neurons, at the origin of ABR wave-I. In Pjvkfl/flMyo15-cre+/- mice, which 
lack pejvakin only in the hair cells, ABR wave-I amplitude and latency at 105 dB SPL 
specifically probed IHC function, because IHC responses to such loud sounds are 
independent of OHC activity (Robles & Ruggero, 2001). The larger wave-I latency (1.58 ms 
in Pjvkfl/flMyo15-cre+/- mice (n = 20) vs. 1.32 ms in Pjvk+/+ littermates (n = 30); p < 0.001) 
and lower wave-I amplitude (37% of the amplitude in Pjvk+/+ littermates; p < 0.001) 
suggested a dysfunction of the IHCs. Controlled sound exposure induced further decreases 
in ABR wave-I amplitude in Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice (48% and 55% of pre-
exposure amplitude, respectively) with respect to Pjvk+/+ mice (108%; p < 0.001 for both 
comparisons) (Figure 2A), demonstrating that Pjvk-/- IHCs are hypervulnerable to sound. As 
shown above, OHCs are also affected by the pejvakin deficiency. Controlled sound-
exposure triggered a mean decrease in the DPOAE amplitude of 16.9 ± 7.2 dB in the 12 to 
20 kHz frequency interval in Pjvk-/- mice with persistent DPOAEs (n = 8; p < 0.0001), and 
an increase in DPOAE threshold, but it had no effect on the DPOAEs of Pjvk+/+ mice (n = 9; 
p = 0.51) (Figure 2B). OHCs lacking pejvakin are, thus, also hypervulnerable to sound.  
We investigated the effect of the absence of pejvakin on the auditory pathway by 
comparing electrically evoked brainstem responses (EEBR) in Pjvk-/- and Pjvkfl/flMyo15-
cre+/- mice (see Extended Experimental Procedures). The amplitudes of the most distinctive 
EEBR waves, E II and E IV, did not differ between the two types of mice (for wave E IV: 
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2.6 ± 1.8 µV in Pjvk-/- mice (n = 18) and 2.2 ± 1.2 µV in Pjvkfl/flMyo15-cre+/- mice (n = 11); 
t-test, p = 0.13). However, following controlled electrical exposure at 200 impulses / s for 1 
minute, as opposed to electric-impulse stimulation with 16 impulses / s for 10 s for pre- and 
post-exposure EEBR tests, E II and E IV EEBR wave amplitudes got 41% and 47% smaller, 
respectively, for at least 3 minutes, in Pjvk-/- mice (n = 5; paired t-test, p = 0.02 and p = 0.01, 
respectively), but were unaffected in Pjvkfl/flMyo15-cre+/- mice (n = 10; p = 0.83) (Figures 
2D, 2G-2I). The E II-E IV interwave interval was 0.41 ms longer in Pjvk-/- mice (n = 5) than 
in Pjvkfl/flMyo15-cre+/- mice (n = 10; p = 0.003) and controlled electrical exposure extended 
this interval by a further 0.15 ms in Pjvk-/- mice only (paired t-test, p = 0.001) (Figures 2H 
and 2I). Likewise, Likewise, the latency interval between ABR wave I and wave IV (the 
counterpart of wave E IV), abnormal in one third of the Pjvk-/- mice tested (with an ABR 
threshold < 95 dB SPL, n = 12) (Figures 2C and 2E), got abnormal in all of them after 
controlled sound-exposure (0.16 ms further increase; paired t-test, p < 0.001). By contrast, it 
remained normal in Pjvkfl/flMyo15-cre+/- mice (n = 10 ears; p = 0.73) (Figures 2C and 2F). 
Thus the absence of pejvakin affects the propagation of action potentials in the auditory 
pathway after both controlled electrical and sound-exposure in the Pjvk-/- mice.        
To clarify whether these abnormalities were of neuronal or glial origin, we 
performed a rescue experiment in Pjvk-/- mice, using adeno-associated virus 8 (AAV8) 
vector-mediated transfer of the murine pejvakin cDNA (AAV8-Pjvk-IRES-EGFP). AAV8 
injected into the cochlea transduces the primary auditory neurons (cochlear ganglion 
neurons) and neurons of the cochlear nucleus (Figure S2A) but not the hair cells. All Pjvk-/- 
mice (n = 7) injected on P3 and tested on P21 had normal ABR interwave I-IV latencies 
(Figure 2J), and their EEBR wave-E IV amplitude was insensitive to controlled electrical 
stimulation (1.91 ± 0.97 µV before and 1.87 µV ± 1.07 after stimulation; paired t-test, p = 
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0.59) (Figures 2K and 2L). The absence of pejvakin thus renders auditory pathway neurons 
hypervulnerable to exposure to mild, short stimuli.  
 
Hypervulnerability to sound in DFNB59 patients  
We then investigated whether the hearing of DFNB59 patients was also 
hypervulnerable to sound-exposure. We tested five patients carrying the p.T54I mutation 
(Delmaghani et al., 2006). Transient-evoked OAEs (TEOAEs) assessing OHC function over 
a broad range of frequencies were detected for all ears, despite the severe hearing 
impairment (hearing threshold increasing from 66 dB HL at 250 Hz to 84 dB at 8 kHz). 
Following minimal exposure to impulse stimuli (clicks at 99 dB nHL), ABR waves were 
clearly identified in response to 250 clicks. When exposure was prolonged to 1000 clicks 
(the standard procedure), wave V, the equivalent of mouse ABR-wave IV, which was 
initially conspicuous, displayed a decrease in amplitude (to 39 ± 30% of its initial 
amplitude) and an increase in latency (of 0.30 ± 0.15 ms) (Figure 3A, 3C, and 3D). In 
parallel, the I-V interwave interval increased by 0.30 ± 0.15 ms. Wave-V amplitude and 
latency recovered fully after 10 minutes of silence (Figure 3B). In control patients with 
sensorineural hearing impairment of cochlear origin matched for ABR thresholds, similar 
sound stimulation did not affect ABR wave-V amplitude (105 ± 14% of the initial amplitude 
after exposure; n = 13 patients) or latency (-0.02 ± 0.07 ms change after exposure) (Figures 
3C and 3D). Exposure of the DFNB59 patients to 1000 clicks also affected TEOAEs (6.1 ± 
5.2 dB nHL decrease in amplitude; paired t-test, p = 0.02). Therefore, as in pejvakin-
deficient mice, the cochlear and neuronal responses of DFNB59 patients were affected by 
exposure to low-energy sound.  
 
Redox status abnormalities and ROS-induced cell damage in the cochlea of Pjvk-/- mice 
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 We studied the Pjvk-/- cochlea by light microscopy on semithin sections, and electron 
microscopy. On P15 and P21, both OHCs and IHCs were normal in number and shape. 
Their hair bundles (the mechanoreceptive structures responding to sound), the ribbon 
synapses of the IHCs and their primary auditory neurons, were unmodified (data not shown). 
On P30, we observed the loss of a few OHCs (16% ± 11%, n = 5 mice), restricted to the 
basal region of the cochlea (tuned to high-frequency sounds). From P30 onwards, OHCs, 
cochlear ganglion neurons, and then IHCs disappeared, and the sensory epithelium (organ of 
Corti) progressively degenerated (Figure S3). 
We investigated possible changes in gene expression in the organ of Corti of P15 
Pjvk-/- mice, by microarrays (see Extended Experimental Procedures). Eighteen genes had 
expression levels at least 1.5-fold higher or lower in Pjvk-/- mice than in Pjvk+/+ mice. 
Marked differences were observed for four genes involved in the redox balance — CypA, 
Gpx2, c-Dct, and Mpv17 — encoding cyclophilin A, glutathione peroxidase 2, c-
dopachrome tautomerase, and Mpv17, respectively (Table S1). All these genes were 
downregulated in Pjvk-/- mice, a result confirmed by quantitative RT-PCR (qRT-PCR) 
(Figure S4A), and all encode anti-oxidant proteins, suggesting that Pjvk-/- mice have 
impaired anti-oxidant defenses (Table S1). 
We thus assessed the level of oxidative stress in the cochlea of P21 Pjvk-/- mice, by 
determining the ratio of reduced to oxidized glutathione (GSH:GSSG). The GSSG content 
was about three times larger than in Pjvk+/+ mice, whereas the GSH content was 23% 
smaller, resulting in a GSH:GSSG ratio in Pjvk-/- cochleas reduced by a factor of 3.4 (Figure 
4A). Pejvakin deficiency thus results in cochlear oxidative stress. 
 We assessed lipid peroxidation by reactive oxygen species (ROS) in Pjvk-/- mice, by 
immunofluorescence-based detection of the by-product 4-hydroxy-2-nonenal (4-HNE). 
Strong immunoreactivity was observed in P60 Pjvk-/- hair cells and cochlear ganglion 
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neurons (Figure S3B). Quantification of lipid peroxidation in microdissected organs of Corti 
from P30 Pjvk-/- and Pjvk+/+ mice, showed a moderate but statistically significant increase of 
the malondialdehyde content in the absence of pejvakin (2.15 ± 0.14 µM in Pjvk-/- vs. 1.84 ± 
0.11 µM in Pjvk+/+ mice; p = 0.04). Thus, pejvakin deficiency led to impaired anti-oxidant 
defenses in the cochlea, resulting in ROS-induced cell damage. 
We then studied electrophysiological features of IHCs and OHCs in the mature 
cochlea of P19-P21 Pjvk-/- mice. In IHCs, the number of synaptic ribbons, Ca2+ currents, and 
synaptic exocytosis were unaffected (Figure S5A). We investigated whether Pjvk-/- mice 
display the main K+ currents found in mature IHCs, specifically IK,f, which plays a major 
part in IHC repolarization and is involved in the high temporal precision of action potentials 
in postsynaptic nerve fibers, IK,s, and IK,n (Oliver et al., 2006). IK,f  current that flows through 
the large conductance voltage- and Ca2+-activated potassium (BK) channels, a well known 
target of ROS (Tang et al., 2004), was detected in only 4 out of 11 Pjvk-/- IHCs, and the 
mean number of spots immunolabeled for the BK α-subunit per IHC was much lower in 
Pjvk-/- mice (5.0 ± 1.4, n = 283 IHCs from 7 mice) than in Pjvk+/+ mice (13.9 ± 2.6, n = 204 
IHCs from 9 mice; t-test, p < 0.001). By contrast, the IK,s and IK,n currents were not affected 
(Figure 4B and Figure S5B). The electromotility of OHCs was moderately impaired in Pjvk-
/- mice (Figure S5C). This contrasted with the total loss of DPOAE in a large majority of 
Pjvk-/- mice from P15 on, even at the highest possible stimulus level of 75 dB SPL. It thus 
pinpointed the existence of an additional defect, likely a mechanoelectrical transduction 
defect, the main determinant of DPOAEs at high stimulus levels (Avan et al., 2013). The 
decrease of the cochlear microphonic potential that reflects mechanoelectrical transduction 
currents through OHCs of the basal-most cochlear region, indeed corroborated the DPOAE 
measurements:  this potential, recorded for a 5 kHz sound stimulus at 95 dB SPL, was 
always larger than 10 µV in Pjvk+/+ mice (n = 8), but fell between 5 µV and 3 µV in the P21 
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Pjvk-/- mice with residual DPOAEs (n = 2), and below 1 µV, in the Pjvk-/- mice without 
persisting DPOAEs (n = 6). Taken together, oxidative stress in the Pjvk-/- cochlea impacts 
various electrophysiological properties of the hair cells, particularly mechanoelectrical 
transduction and K+ current through BK channels. 
 Mitochondrial defects are a common cause of ROS overproduction. However, we 
didn’t find evidence that mitochondria were damaged, as vulnerability of the mitochondrial 
membrane potential, ∆ψm, to the uncoupler carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP) in the organ of Corti and cochlear ganglion was 
similar in P17-P30 Pjvk-/- and Pjvk+/+ mice, and analysis of Pjvk-/- hair cells by transmission 
electron microscopy (TEM) revealed no mitochondrial abnormalities (Figure S5D and data 
not shown). 
 
Pejvakin is a peroxisome-associated protein 
By using Pjvk-/- cochlea as control, we found that neither the commercially available 
antibodies nor our initial polyclonal antibody (Delmaghani et al., 2006) specifically 
recognized pejvakin (data not shown). Given the limited divergence of the pejvakin amino-
acid sequence among vertebrates, we tried to elicit an immune response in Pjvk-/- mice (see 
Experimental Procedures). The monoclonal antibody obtained, Pjvk-G21, labeled 
peroxisomes stained by peroxisome membrane protein 70 (PMP70) antibodies in transfected 
HeLa cells expressing pejvakin (Figure S6A) and in the human HepG2 hepatoblastoma cell 
line, which is particularly rich in this organelle (Figure 5A). The specificity of the Pjvk-G21 
antibody was demonstrated by the immunolabeling of peroxisomes in the hair cells of 
Pjvk+/+, but not Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice  (Figure 5B and S6B). 
Prediction programs failed to detect the PTS1 or PTS2 motifs in the pejvakin 
sequence  (Mizuno et al., 2008), the targeting signals for the importation of peroxisomal 
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matrix proteins into the organelle (Smith and Aitchison, 2013), suggesting that pejvakin is a 
peroxisomal membrane or membrane-associated protein.  
 
Structural abnormalities of peroxisomes in the hair cells of Pjvk-/- mice 
We investigated the distribution and morphology of peroxisomes by TEM. 
Peroxisomes were identified on the basis of catalase activity detection using 3,3'-
diaminobenzidine as substrate. We focused on OHCs, the first to display a dysfunction in 
Pjvk-/- mice. On P30 but not P15, both the distribution and shape of peroxisomes differed 
between Pjvk-/- and Pjvk+/+ mice (Figure 5E). In Pjvk+/+ OHCs, the peroxisomes were 
restricted to an area immediately below the cuticular plate. In Pjvk-/- mice, the peroxisomes 
located just below the cuticular plate were slightly larger than those in Pjvk+/+ mice. 
Strikingly, irregular catalase-containing structures, some of which were juxtaposed, were 
present in the perinuclear region, in the immediate vicinity of the nuclear membrane of all 
Pjvk-/- OHCs, but not of Pjvk+/+ OHCs (Figure 5E). The lack of pejvakin thus results in 
peroxisome abnormalities in OHCs after the onset of hearing. 
 
Pejvakin is involved in oxidative stress-induced peroxisome proliferation  
 In HepG2 cells, protrusions emerging from some peroxisomes, the first step of 
peroxisome biogenesis from pre-existing peroxisomes, were immunoreactive for pejvakin. 
String-of-beads structures corresponding to elongated and constricted peroxisomes, 
preceding final fission (Smith and Aitchison, 2013), were also pejvakin-immunoreactive, 
suggesting a role of this protein in peroxisome proliferation (Figure S6C). Peroxisomes 
actively contribute to cellular redox balance, by producing and scavenging/degrading H2O2 
through a broad spectrum of oxidases and peroxidases (especially catalase), respectively 
(Schrader and Fahimi, 2006). Because Pjvk-/- mice displayed features of marked oxidative 
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stress in the cochlea, we investigated the possible role of pejvakin in peroxisome 
proliferation in response to oxidative stress induced by H2O2 (Lopez-Huertas et al., 2000). 
Embryonic fibroblasts derived from Pjvk+/+ and Pjvk-/- mice were exposed to H2O2 (see 
Extended Experimental Procedures). In unexposed cells, the number of peroxisomes was 
similar between the two genotypes (t-test, p = 0.82). After H2O2 treatment, it increased by 
46% in Pjvk+/+ fibroblasts (p = 0.004), but remained unchanged in Pjvk-/- fibroblasts (p = 
0.83), resulting in a statistically significant difference between the two genotypes (p < 
0.001) (Figures 5C and S7A).  
 We then asked whether mutations reported in DFNB9 patients also affect peroxisome 
proliferation. We assessed the number of peroxisomes in transfected HeLa cells producing 
EGFP alone, EGFP and murine pejvakin, or EGFP and one of the mutated forms of murine 
pejvakin carrying the mutations responsible for DFNB59 (p.T54I, p.R183W, p.C343S, or 
p.V330Lfs*7). Cells producing the non-mutated pejvakin had larger numbers of 
peroxisomes than cells producing EGFP alone, whereas cells producing any of the mutated 
forms of pejvakin (mutPjvk-IRES-EGFP) had smaller peroxisome numbers. In addition, 
many of these cells contained enlarged peroxisomes, a feature typical of peroxisome 
proliferation disorders (Ebberink et al., 2012) (Figure 5D and S7B). Together, these results 
strongly suggest that pejvakin is directly involved in the production of new peroxisomes 
from pre-existing peroxisomes. 
 
Upregulation of Pjvk cochlear transcription and peroxisome proliferation in response 
to sound 
We then asked whether pejvakin is involved in the physiological response to sound. 
We first assessed the transcription of Pjvk, and of CypA, Gpx2, c-Dct, and Mpv17 that were 
downregulated in Pjvk-/- mice, in microdissected organs of Corti from P21 wild-type mice, 
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with or without prior sound-stimulation (5-20 kHz, 105 dB SPL for 1 hour; see Extended 
Experimental Procedures). Transcript levels were analyzed by qRT-PCR at various times (1, 
3, 6, and 18 hours) after sound-exposure (Figure 6A). Pjvk transcript levels had increased by 
factors of 1.9 ± 0.1 and 3.5 ± 0.7, mean ± SEM, after 1 hour and 6 hours, respectively. 
CypA, c-Dct and Mpv17 were also upregulated after 6 hours (by factors of 6.6 ± 1.2, 4.3 ± 
0.6 and 1.5 ± 0.1, respectively), as were c-Fos and Hsp70, used as a positive control, but 
Gpx2 was not. Thus, noise-exposure leads to an upregulation of the transcription of Pjvk and 
of genes downregulated in Pjvk-/- mice, and this effect is dependent on acoustic energy level 
(Figure S4B).    
This result predicted that sound-exposure would lead to peroxisome proliferation in 
the auditory system of wild-type mice. Six hours after exposure (5-20 kHz, 105 dB SPL for 
1 hour), the numbers of peroxisomes were unchanged (34.5 ± 0.8 and 35.9  ± 1.0, mean ± 
SEM, per IHC from unexposed and sound-exposed mice, respectively, n = 75 cells from 6 
mice; t-test, p = 0.25). However, at 48 hours, they had markedly increased, by a factor of 
2.3, in both IHCs and OHCs (84.7 ± 5.0 per IHC and 16.5 ± 1.0 per OHC, n = 90 cells and n 
= 150 cells from 6 mice, respectively) compared to unexposed mice (36.8 ± 3.0 per IHC and 
7.3 ± 0.4 per OHC, n = 90 cells and n = 150 cells from 6 mice, respectively; t-test, p < 
0.0001 for both comparisons). The number of peroxisomes had also increased, by 35%, in 
the dendrites of primary auditory neurons (1.7 ± 0.1 and 2.3 ± 0.2 peroxisomes per µm of 
neurite length, n = 40 neurites from 5 unexposed and 5 sound-exposed Pjvk+/+ mice, 
respectively; t-test, p = 0.003) (Figure 6B).  
 
Therapeutic approaches in Pjvk-/- mice 
Based on these results, we tested whether the classical anti-oxidant drug N-acetyl 
cysteine (NAC) (either alone or associated with α-lipoic acid and α-tocopherol; see 
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Extended Experimental procedures), administered to Pjvk-/- pups could improve their 
hearing. The ABR thresholds of P21 NAC-treated Pjvk-/- pups (n = 21) were about 10 dB 
lower than those of untreated Pjvk-/- pups (n = 24) for all frequencies tested (t-test, p < 0.001 
for all comparisons) (Figure 7A). The amplitude of the ABR wave I elicited at 105 dB SPL 
(4.35 ± 1.16 µV, n = 21), was the same as that of Pjvk+/+ mice (4.36 ± 1.15 µV, n = 18; t-test, 
p = 0.97), and greater than that of untreated Pjvk-/- mice (1.88 ± 1.07 µV, n = 24; t-test, p < 
0.001) (Figure 7B). EEBRs were more resistant to the high-rate electrical stimulation in 
treated than in untreated mutant mice (Figure 7C). Conversely, NAC had no beneficial effect 
on OHCs (data not shown). The association of NAC with α-lipoic acid and α-tocopherol did 
not perform any better (data not shown). 
Full recovery of the neuronal phenotype was achieved by the intracochlear injection 
of AAV8-Pjvk-IRES-EGFP (see above). As hair cells are not transduced by AAV8, we 
investigated whether AAV2/8, which transduces hair cells only (Figure S2B), could rescue 
the Pjvk-/- hair-cell phenotype. The auditory function of Pjvk-/- mice (n = 7, four pups per 
cage in every experiment) receiving intracochlear injections of AAV2/8-Pjvk-IRES-EGFP 
on P3 was assessed on P21, and the percentage of transduced IHCs and OHCs was evaluated 
in each injected and contralateral (not injected) cochlea, on the basis of EGFP fluorescence. 
Improvements in ABR thresholds of 20 to 30 dB SPL with respect to untreated mice were 
observed for frequencies between 10 and 20 kHz (t-test, p < 0.001 for all comparisons; 
Figure 7D). Upon injection of AAV2/8-EGFP, DPOAEs, ABR thresholds, and ABR wave I 
amplitude and latency were similar to those of untreated Pjvk-/- mice (data not shown). A 
partial reversion of the OHC dysfunction was obtained, with detectable DPOAEs in pejvakin 
cDNA-treated cochleas (threshold 54.0 ± 10.7 dB), but not in contralateral, untreated 
cochleas (Figure 7E). DPOAE thresholds were linearly correlated (r2 = 0.74, p < 0.001) with 
the number of EGFP-tagged OHCs (Figure 7F), suggesting that the normalization of 
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DPOAE thresholds may be possible if all OHCs could be transduced. The latency of the 
ABR wave I in response to a 105 dB SPL stimulation decreased significantly (1.38 ± 0.11 
ms for the treated ears; n = 6, vs. 1.53 ± 0.10 ms for the contralateral, untreated ears; paired 
t-test, p = 0.03) (Figure 7G), and its amplitude increased into the normal range (7.34 ± 0.80 
µV vs. 2.93 ± 0.92 µV; paired t-test, p < 0.001) (Figure 7H), in relation to the number of 
EGFP-tagged IHCs (r2 = 0.89 for wave I amplitude, p < 0.001; Figure 7I). No correction of 
the interwave I-IV latency was observed, as expected (data not shown).  
Finally, we investigated the effect of the transduction of Pjvk-/- IHCs by AAV2/8-
Pjvk-IRES-EGFP on their peroxisomes. Before sound-exposure, the numbers of 
peroxisomes in IHCs of P21 Pjvk-/- and AAV2/8-Pjvk-IRES-EGFP injected Pjvk-/- mice did 
not differ from that of Pjvk+/+ mice (30.5 ± 1.9, 32.3 ± 2.1, and 36.8  ± 3.0 peroxisomes, 
mean ± SEM per IHC, n = 60 cells from 4 Pjvk-/- and 4 AAV2/8-Pjvk Pjvk-/- mice, and n = 
90 cells from 6 Pjvk+/+ mice, respectively; t-test, p = 0.11 and p = 0.30, respectively).  By 
contrast, 48 hours after sound-exposure (5-20 kHz) at 105 dB SPL for 1 hour, the number of 
peroxisomes had decreased by 63% in Pjvk-/- IHCs (30.5 ± 1.9 and 11.2 ± 1.3 peroxisomes 
per IHC, n = 75 cells from 5 unexposed and 5 sound-exposed Pjvk-/- mice, respectively; t-
test, p < 0.0001), and enlarged PMP70-labeled structures were present close to the nucleus 
(Figure 7J). In response to the same sound but of a lower intensity, i.e. 97 dB SPL for 1 
hour, the number of peroxisomes was unchanged in Pjvk-/- IHCs  (30.5 ± 1.9 and 34.6 ± 2.3 
peroxisomes per IHC, n = 60 cells from 4 unexposed and 4 sound-exposed Pjvk-/- mice, 
respectively; t-test, p = 0.17), and no enlarged PMP70-stained structures were detected (data 
not shown). The absence of pejvakin thus resulted in defective sound-induced peroxisomal 
proliferation (both at 105 dB SPL and 97 dB SPL), and even, in peroxisome degeneration (at 
105 dB SPL) in IHCs. In Pjvk-/- mice injected with AAV2/8-Pjvk-IRES-EGFP on P3 and 
exposed to 105 dB SPL for 1 hour on P21, enlarged PMP70-labeled structures were no 
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longer detected in transduced IHCs, and the number of peroxisomes increased by 35% (32.3 
± 2.1 and 43.7 ± 3.0 peroxisomes per IHC, n = 60 cells from unexposed and exposed 
transduced Pjvk-/- IHCs, respectively; t-test, p = 0.002) (Figure 7J). We conclude that 
pejvakin re-expression fully protects Pjvk-/- IHCs from the degenerescence of peroxisomes, 
and partially restores their impaired adaptive proliferation. 
 
DISCUSSION 
Noise-induced hearing loss (NIHL) is the second most common form of sensorineural 
hearing impairment after presbycusis in the U.S.A. (Dobie, 2008). We describe here a 
genetic form of NIHL, by showing that pejvakin deficiency in mice and DFNB59 patients 
leads to hypervulnerability to sound, due to a peroxisomal deficiency. To our knowledge, a 
peroxisomal cause of an isolated (non-syndromic) form of inherited deafness has not been 
reported yet. The peroxisome emerges as a key organelle in the redox homeostasis of the 
auditory system, for coping with the overproduction of ROS induced by high levels of 
acoustic energy. 
Acoustic energy is the main determinant of NIHL. The LEX,8 hour (for level of 
exposure over an 8-hour workshift) index has been defined such that an LEX,8 hour of X dB 
delivers the same energy as a stable sound of X dB played over a period of eight hours. 
Chronic occupational exposures to less than 85 dB (or 80 dB, depending on the country) are 
deemed safe. In Pjvk-/- mice, a single exposure to 63 dB LEX,8 hour increased hearing 
thresholds by 30 dB, with full recovery occurring after about two weeks. By contrast, a ten-
times more energetic exposure to a LEX,8 hour of 73 dB in wild-type mice of the same strain 
produces only an 18 dB shift in threshold, with a recovery time of 12 hours (Housley et al., 
2013). This hypersensitivity of Pjvk-/- mice to noise suggests that the LEX,8 hour of about 83 
dB for a cage of 10 pups is sufficient to account for permanent hearing loss in these Pjvk-/- 
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pups, whilst some of those housed in small numbers in quiet rooms can display near-normal 
hearing thresholds (see Figure 1C). Likewise, the auditory function of DFNB59 patients was 
transiently affected by a 57 dB LEX,8 hour exposure, routinely used in ABR tests. 
NIHL involves the excessive production of ROS, overwhelming the anti-oxidant defense 
system and causing irreversible oxidative damage to DNA, proteins, and lipids within the 
cell (Henderson et al., 2006). Noise-induced oxidative stress results in the production of 
H2O2 and other ROS as by-products, thought to derive from the intense sollicitation of 
mitochondrial activity, and several mouse mutants with mitochondrial defects are prone to 
NIHL (Ohlemiller et al., 1999; Brown et al., 2014). Our studies of pejvakin-deficient mouse 
mutants and rescue experiments targeting the hair cells and auditory neurons unambiguously 
show that IHCs, OHCs, primary auditory neurons and neurons of the cochlear nucleus are 
hypervulnerable to sound in the absence of pejvakin, which is consistent with previous 
results showing that hair cells and neurons of the auditory system are targets of NIHL 
(Wang et al., 2002; Kujawa & Liberman, 2009; Imig and Durham, 2005). However, our 
study goes one step further, by implicating a possible common mechanism:  peroxisomal 
failure, the importance of which is demonstrated by the impairment of the redox 
homeostasis caused by pejvakin deficiency. It also reveals a major cause of the unusually 
high level of phenotypic variability observed in pejvakin-deficient mice and humans: the 
difference in sound-exposure and the inability of the peroxisomes to cope with the resulting 
activity-dependent oxidative stress in the absence of pejvakin. Incidentally, this can account 
for the apparent paradox that mice carrying the R183W mutation in pejvakin displayed a 
much more severe neural pathway defect than the Pjvk-/- mice (Delmaghani et al., 2006).  
Due to the preservation of hair cell functions, the auditory neurons of R183W mutant mice 
should be strongly stimulated, whereas the early permanent damage to cochlear hair cells in 
Pjvk-/- mice acts as a protective "muffler" of the neuronal pathway. 
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In mammals, the number and metabolic functions of peroxisomes differ between cell 
types. However, all cell types are able to adapt rapidly to modifications in physiological 
conditions by changing the number, shape, size, and molecular content of peroxisomes, 
resulting in considerable functional plasticity of these organelles (Schrader et al., 2012; 
Smith and Aitchison, 2013). Our experiments on Pjvk-/- and Pjvk+/+ mouse embryonic 
fibroblasts stressed with H2O2 showed that pejvakin is critically involved in the oxidative 
stress-induced proliferation of peroxisomes through growth and fission of pre-existing 
peroxisomes. The molecular machinery underlying this adaptive process is still poorly 
understood beyond the involvement of Pex11α (Li et al., 2002). Of note, the absence of 
pejvakin only affects the proliferation of peroxisomes from pre-existing peroxisomes, but 
not the constitutive biogenesis of this organelle. Accordingly, structural abnormalities of 
peroxisomes in Pjvk-/- mice became apparent only after hearing onset, in the context of the 
oxidative stress produced by noise-exposure. By contrast, the PEX gene defects causing 
Zellweger syndrome spectrum (ZSS) disorders (Waterham & Ebberink, 2012) and 
rhizomelic chondrodysplasia punctata affect the constitutive biogenesis of peroxisomes. 
Hearing impairment in ZSS disorders involves a severe impairment of neuronal conduction, 
and has been attributed to defects in the synthesis of two essential myelin sheath 
components — plasmalogens and docosahexaenoic acid —, which is critically dependent on 
peroxisomes. Our results suggest that ZSS also includes a defective redox balance in the hair 
cells and neurons of the auditory system.  
In the context of noise-exposure, the upregulation of Pjvk transcription in the cochlea 
and the subsequent peroxisome proliferation in the hair cells and auditory neurons of wild-
type mice suggest that pejvakin-dependent peroxisome proliferation in the auditory system 
is part of the physiological response to high levels of acoustic energy that result in increased 
amounts of ROS. This and the marked oxidative stress detected in the Pjvk-/- cochlea imply 
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that the proliferation of peroxisomes plays an anti-oxidant role, similar to that reported in 
other cell types (Santos et al., 2005; Diano et al., 2011). The rapid elevation of the hearing 
threshold in Pjvk-/- mice in response to low-energy sounds and the increase in interwave I-IV 
latency observed in DFNB59 patients within a few seconds are consistent with an activity-
dependent H2O2 production that, due to impaired cellular redox homeostasis, results in 
concentrations of H2O2 high enough to impact on the activity of various target proteins 
including ion channels and transporters (Rice, 2011). The worsening of hearing sensitivity, 
two days later, in the mutant mice lacking pejvakin, exacerbated by putting back the mice in 
a noisy environment, fits the picture of the absence of sound-induced biogenesis of 
peroxisomes (with their degeneration occurring in a high acoustic energy environment). We 
thus conclude that the hypervulnerability of Pjvk-/- mice and DFNB59 patients to sound does 
not result simply from an exacerbation, by sound, of a pre-existing redox balance defect, but 
is the consequence of the impaired adaptive proliferation of peroxisomes in the absence of 
pejvakin. Both the defective peroxisome proliferation in IHCs of Pjvk-/- mice in response to 
sound-exposure and its partial recovery by pejvakin cDNA transfer support this conclusion. 
A full recovery of the adaptive peroxisome proliferation produced by sound-exposure may 
require higher concentrations of pejvakin or the sound-induced modulation of Pjvk 
transcription (see Figure 6A), which was missing in our rescue experiments (pejvakin cDNA 
expression being driven by a constitutive promoter). 
 In patients with hearing impairment, the amplification of sound by hearing aids or 
direct electrical stimulation of the auditory nerve by a cochlear implant delivers a stimulus 
with an energy level similar to that shown here to worsen the hearing impairment of Pjvk-/- 
mice within one minute of sound exposure. Therefore, in cases of peroxisomal deficiency, as 
in DFNB59, specific protection against redox homeostasis failure is essential. Patients with 
such conditions should avoid noisy environments and a beneficial effect of hearing devices 
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should require an anti-oxidant protection. N-acetyl cysteine was the only antioxidant drug 
tested here to display some, albeit limited, efficacy. By contrast, AAV-mediated gene 
therapy could potentially provide full protection. Finally, deciphering the sound stress-
induced protective signaling pathway involving pejvakin, might lead to the discovery of 
therapeutic agents for NIHL. 
 
EXPERIMENTAL PROCEDURES 
 
Audiological studies in mice 
Auditory tests were performed in an anechoic room, on anesthetized animals for which core 
temperature was maintained at 37°C (see Extended Experimental Procedures).  
 
Audiological tests in patients 
Informed consent was obtained from all the subjects included in the study. Pure-tone 
audiometry was performed, with air- and bone-transmitted tones. Hearing impairment was 
assessed objectively, by measuring ABRs and transient-evoked otoacoustic emissions 
(TEOAEs). The nonlinear TEOAE recording procedure was used (derived from the ILO88 
system), making it possible to extract TEOAEs from linear reflection artifacts from the 
middle ear, and to evaluate background noise. TEOAE responses were analyzed in 1 kHz-
wide bands centered on 1, 2, 3 and 4 kHz. 
 
Generation of an anti-pejvakin monoclonal antibody  
The 3’-end of the coding sequence of the Pjvk cDNA (NCBI: NM_001080711.2) was 
inserted into a pGST-parallel-2 vector (derived from pGEX-4T-1; Amersham). The resulting 
construct, encoding the C-terminal region of pejvakin (residues 290-352; RefSeq: 
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NP_001074180.1) fused to an N-terminal glutathione S-transferase tag, was introduced into 
E. coli BL21-Gold (DE3) competent cells (Stratagene). The pejvakin protein fragment was 
purified on a glutathione-Sepharose 4B column, then subjected to size-exclusion 
chromatography and used as the antigen for immunization. Antibodies were produced by 
immunizing Pjvk-/- mice. An immunoglobulin G monoclonal antibody (KD of 6 x 10-8 M), 
Pjvk-G21, was selected by ELISA on immunogen-coated plates.  
 
Statistical analyses 
Quantitative data are presented as mean ± SD, unless otherwise mentioned. Statistical 
analyses were performed using GraphPad. Data were analyzed by paired or unpaired 
Student’s t-tests, and, for multiple comparisons, either by one-way or two-way analyses of 
variance (ANOVA), or by t-tests with the Bonferroni correction. Statistical significance of 
the differences observed between groups is defined as p < 0.05. 
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FIGURE LEGENDS 
Figure 1. Hearing loss variability and greater sensitivity to controlled sound-exposure 
in Pjvk-/- mice. (A) ABR thresholds at 10 kHz in P30 Pjvk+/+ (n = 26 mice) and Pjvk-/- (n = 
48 mice) littermates. (B) DPOAE thresholds at 10 kHz in P30 Pjvk+/+ (n = 14 mice) and 
Pjvk-/- (n = 48 mice) littermates. In ears with no DPOAE, even at 75 dB SPL (the highest 
sound intensity tested), DPOAE thresholds were arbitrarily set at 80 dB SPL. (C) 
Relationship between the number of pups raised together (determining sound levels in the 
immediate environment) and ABR thresholds at 10 kHz in P21 Pjvk-/- pups. Inset: Time-
frequency analysis of a mouse pup’s vocalization. Pup calls from P0 to P21 form harmonic 
series of about 5 kHz, with the most energetic harmonic at about 10 kHz. In a 12-pup litter, 
call levels reach 105 ± 5 dB SPL at the entrance to the ear canals of the pups. (D) ABR 
thresholds at 10 kHz in P30 Pjvk+/+ and Pjvk-/- mice before (dots) and after (crosses) 
controlled sound-exposure. n.s., not significant; *** p < 0.001. 
 
Figure 2. Effects on auditory function of brief exposure to moderately intense stimuli 
in Pjvk+/+, Pjvk-/-, and Pjvkfl/flMyo15-cre+/- mice. (A-C) ABR wave I amplitude (A), 
DPOAE amplitude (B) and ABR interwave I-IV latency (C) in Pjvk+/+, Pjvk-/- and 
Pjvkfl/flMyo15-cre+/- mice, before (dots) and after (crosses) controlled sound-exposure, 
revealing the hypervulnerability to sound of both types of cochlear hair cells (IHCs and 
OHCs) and of the neural pathway. (D) EEBR wave E IV amplitude before and after 
controlled electrical exposure in Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice, abnormal and 
hypervulnerable only when pejvakin is absent from auditory neurons (Pjvk-/- mice). (E and 
F) Examples of ABRs in Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice: the latency of wave I is 
affected by controlled sound-exposure in both mutant mice, and wave IV displays an 
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additional increase in latency only in Pjvk-/- mice. (G-I) Examples of EEBRs in Pjvk+/+ (G), 
Pjvk-/- (H), and Pjvkfl/flMyo15-cre+/- (I) mice; EEBRs are affected by controlled electrical 
exposure only in Pjvk-/- mice. (J-L) Neuronal function rescue in Pjvk-/- mice by transduction 
with AAV8-Pjvk: effects on ABR interwave I-IV latency (J), on EEBR wave E IV 
amplitude and its hypervulnerability to electrical stimulation (K), and on EEBR interwave E 
II-E IV latency (one example is shown in L, to be compared with H). Vertical arrows 
indicate the positions of waves I and IV on ABR traces, and of waves E II and E IV on 
EEBR traces. n.s., not significant; *** p < 0.001. Error bars represent the SD.  See also 
Figure S2A. 
 
Figure 3. Hypervulnerability to sound in DFNB59 patients. (A) ABR waves I, III, and V 
(vertical arrows) in one ear of a patient carrying the PJVK p.T54I mutation, in response to 
250, 500, and 1000 impulse stimuli (clicks) at 99 dB nHL. (B) Repeated ABRs after 10 
minutes of silence, with an even larger vulnerability of waves I, III, and V. (C and D) 
Distributions of the amplitude (C) and latency (D) of ABR wave V in the tested sample of 
p.T54I patients (n = 8 ears), and in a control group of patients (n = 13) with cochlear hearing 
impairment and matched ABR thresholds, before and after exposure to clicks #250 to #1000. 
Boxes extend from the 25th to the 75th percentile. Horizontal bars and vertical bars indicate 
median values and extremes, respectively. Unlike the unaffected controls, all p.T54I patients 
displayed markedly decreased amplitudes and increased latencies. 
 
Figure 4. Increased oxidative stress and ROS-induced cell damage in the Pjvk-/- 
cochlea. (A) Reduced-glutathione (GSH) (left bar chart), oxidized-glutathione (GSSG) 
(middle bar chart) contents, and GSH:GSSG ratio (right bar chart), in P21 Pjvk-/- versus 
Pjvk+/+ cochlea. Error bars represent the SEM of 3 independent experiments. See also Figure 
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S3.  (B) Marked decrease in the BK α-subunit immunolabeling in Pjvk-/- IHCs. Left: P20 
Pjvk+/+ and Pjvk-/- IHCs. Scale bar is 5 µm. Right: quantitative analysis of BK channel 
clusters. Error bars represent the SD.  See also Figure S5B. * p < 0.05,  *** p < 0.001.  
 
Figure 5. Pejvakin is a peroxisome-associated protein involved in the oxidative stress-
induced peroxisomal proliferation. (A, B) Immunolabeling of PMP70 and endogenous 
pejvakin in a HepG2 cell (A) and in two P20 Pjvk+/+ IHCs (B). See also Figure S6B.	   (C) 
Number of peroxisomes in Pjvk+/+ and Pjvk-/- mouse embryonic fibroblasts (MEFs) 
subjected to 0.5 mM H2O2, versus untreated MEFs (n = 30 cells for each condition). See also 
Figure S7A. (D) Untransfected HeLa cells (NT), and transfected cells producing either 
EGFP alone or EGFP together with the wild-type pejvakin (Pjvk) or a mutated Pjvk (p.T54I, 
p.R183W, p.C343S, or p.V330Lfs*7). Left panel: Bar chart showing the numbers of 
peroxisome per cell 48 hours after transfection. There were on average 33% more 
peroxisomes in cells producing both EGFP and Pjvk (n = 200) than in cells producing EGFP 
alone (n = 150). Right panel: for every range of enlarged peroxisome size, x (0.6-0.8 µm, 
0.8-1.0 µm, and > 1.0 µm), in two perpendicular directions, the proportion of cells 
containing at least one peroxisome. See also Figure S7B. (E) Abnormalities in shape and 
distribution of peroxisomes in mature Pjvk-/- OHCs detected by TEM (P30 Pjvk-/- (middle 
and right panels) and Pjvk+/+ (left panel) OHCs). Insets (middle panel) show enlarged views 
of individual peroxisomes. In Pjvk+/+ OHCs, peroxisomes are grouped just under the 
cuticular plate (CP) (arrowheads), with none detected in the perinuclear region (n = 33 
sections, upper bar chart). In Pjvk-/- OHCs, some peroxisomes remain under the CP 
(arrowheads), but catalase-containing structures, misshapen peroxisomes (arrows), are 
detected in the perinuclear region  (n = 24 sections, upper bar chart). Peroxisomes located 
under the CP are larger in Pjvk-/- OHCs (n = 92 peroxisomes) than in Pjvk+/+ OHCs (n = 89 
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peroxisomes) (lower bar chart). N: cell nucleus. ** p < 0.01, *** p < 0.001. Error bars 
represent the SEM.  Scale bars are 5 µm in (A) and (B), and 0.5 µm in (E).	  
 
Figure 6. Effect of exposure to loud sounds on the cochlear expression of Pjvk and the 
number of peroxisomes in cochlear hair cells and ganglion neurons. (A) Pjvk, c-Dct, 
CypA, Mpv17, and Gpx2 transcript levels assessed by qRT-PCR in P21 Pjvk+/+ organ of 
Corti, 1, 3, 6, and 18 hours after sound-exposure (5-20 kHz, 105 dB SPL for 1 hour). The 
levels of c-Fos and Hsp70 transcripts were used as positive controls. See also Figure S4B. 
(B) Peroxisome proliferation in P21 Pjvk+/+ hair cells and cochlear ganglion neurons after 
sound-exposure (same conditions as in A). Peroxisomes were counted 48 hours after sound-
exposure. OHCs, IHCs, and neuronal processes stained for F-actin, myosin VI, and 
neurofilament protein NF200, respectively. In OHCs and IHCs, the peroxisomes are located 
below the CP and throughout the cytoplasm, respectively. For OHCs, both a lateral view and 
a transverse optical section at the level of CP (scheme on the right) are shown. The number 
of peroxisomes was increased in OHCs, IHCs, and dendrites after sound-exposure. N: cell 
nucleus. *** p < 0.001. Error bars represent the SEM. Scale bars are 5 µm.  
 
Figure 7. Therapeutic approaches in Pjvk-/- mice. (A-C) Effect of N-acetyl cysteine 
(NAC) on auditory function in Pjvk-/- mice. (A) ABR thresholds in untreated vs. NAC-
treated P21 Pjvk-/- mice. (B) ABR wave I amplitude for 10 kHz tone bursts in Pjvk+/+ and 
untreated Pjvk-/- vs. NAC-treated Pjvk-/- mice at P21 (C) EEBR wave E IV amplitude before 
(dots) and after (crosses) controlled electrical stimulation of the cochlear nerve at 200 
impulses/s for 1 minute in Pjvk+/+, untreated Pjvk-/-, and NAC-treated Pjvk-/- mice. (D-I) 
Effect of AAV2/8-Pjvk-IRES-EGFP transferred into the cochlear hair cells on the auditory 
function of Pjvk-/- mice. See also Figure S2B. (D) ABR thresholds at 10, 15, and 20 kHz in 
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AAV2/8-Pjvk-IRES-EGFP treated vs. untreated Pjvk-/- mice. (E, H) DPOAE threshold (E) 
and ABR wave I amplitude (H) at 10 kHz in treated vs. untreated contralateral ears. (G) 
ABR wave I latency in treated vs. untreated contralateral ears. (F) Correlation between 
DPOAE thresholds and the proportion of EGFP-tagged (i.e. transduced) OHCs. Six 
untreated ears have no recordable DPOAE (threshold arbitrarily set at 80 dB SPL, red 
diamond). (I) Correlation between ABR wave I amplitude at 10 kHz, 105 dB SPL and the 
percentage of transduced IHCs (EGFP-tagged). (J) Effect of AAV2/8-Pjvk-IRES-EGFP on 
the peroxisomes in Pjvk-/- IHCs. Upper and lower panels show and quantify (bar charts) the 
peroxisomes in untreated mice 48 hours after sound-exposure (5-20 kHz, 105 dB SPL for 1 
hour) (peroxisome abnormalities are indicated by arrowheads). Error bars represent the SD 
in (A-I), and the SEM in (J). n.s., not significant; * p < 0.05, ** p < 0.01, *** p < 0.001.  
 
Supplemental Information 
EXTENDED EXPERIMENTAL PROCEDURES 
Animal handling 
Animals were housed in the Institut Pasteur animal facilities, which are accredited by the 
French Ministry of Agriculture for experimentation on live mice (accreditation 75-15-01, 
issued on September 6th, 2013 in application of the French and European regulations on the 
care and protection of laboratory animals (EC Directive 2010/63, French Law 2013-118, 
February 6th, 2013). The corresponding author confirms that the protocols were approved by 
the veterinary staff of the Institut Pasteur animal facility, and were performed in accordance 
with the NIH Animal Welfare Insurance #A5476-01 issued on July 31st, 2012.  
 
Gene targeting, genotyping, and RT-PCR 
We designed a targeting vector, in which exon 2 of Pjvk and the neomycin selection cassette 
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(Pgk-neo) were flanked by loxP sites. A negative selection cassette encoding the diphtheria 
toxin A fragment was inserted at the 3’-end of the Pjvk targeting sequence (Figure S1A). 
CK35 embryonic stem (ES) cells (Kress et al., 1998), derived from a 129/Sv mouse embryo, 
were electroporated with the purified, linearized targeting vector, and plated on G418 
selective medium, as previously described (Matise et al., 1999). Approximately 300 
recombinant ES cell clones were obtained, 12 of which were correctly targeted. The 
homologous recombinant event was confirmed by PCR, with primers specific for the 5' and 
3' genomic sequences outside the region used in the targeting vector, and specific for the 
Pgk-neo sequence. The sequences of the PCR primers used to genotype the floxed Pjvk 
allele are available on request. The integration of the recombinant DNA construct was 
confirmed by Southern blot analysis and PCR amplification of genomic DNA extracted 
from mouse tails. Two independent clones were used to create chimeric mice displaying 
germline transmission, by injection into C57BL/6J blastocysts. Male chimeras were crossed 
with C57BL/6J females to produce heterozygous animals. Mice heterozygous for the floxed 
Pjvk allele were crossed with Pgk-crem deleter mice carrying the cre recombinase gene 
driven by the early-acting ubiquitous phosphoglycerate kinase-1 gene promoter (Lallemand 
et al., 1998), to obtain Pjvk-knockout (Pjvk-/-) mice. The targeted deletion of exon 2 was 
confirmed by PCR analysis. 
Mice with a conditional knockout of Pjvk (Pjvkfl/flMyo15-cre+/-), in which expression of the 
deleted Pjvk was restricted to the inner ear sensory cells, were generated by crossing mice 
carrying the floxed Pjvk allele with transgenic mice expressing the cre recombinase gene 
under the control of the myosin-15 gene promoter (Caberlotto et al., 2011). Auditory 
function was analyzed in ubiquitous knockout and conditional knockout mice. All studies 
were performed in a C57BL/6J-129/Sv mixed genetic background. 
For RT-PCR analysis of Pjvk transcript levels, total RNA was extracted from the inner ears 
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of Pjvk+/+ and Pjvk-/- P7 mice with the NucleoSpin® RNA II kit (Macherey-Nagel). The 
sequences of the PCR primers used to characterize the Pjvk transcript (Figure S1B) are 
available on request. 
 
Auditory tests, controlled sound-exposure, and controlled electrical stimulation of the 
auditory nerve in mice 
Mice were anesthetized by intraperitoneal injection of a mixture of ketamine and 
levomepromazin (100 mg/kg: 5 mg/kg), and their core temperature was maintained at 37°C 
with the aid of a servo-controlled heating pad. The DPOAE at a frequency 2f1-f2 was 
recorded in response to two primary tones of similar energy levels, f1 and f2, with f2/f1 = 1.20 
(CubeDis system, Mimosa Acoustics; ER10B microphone, Etymotic Research). Frequency f2 
was swept at 1/10th octave steps from 4 to 20 kHz, and DPOAE threshold was plotted 
against frequency f2 (primary tone levels increased from 20 to 70 dB SPL in 10 dB steps, 
then to 75 dB SPL). The DPOAE threshold was defined as the smallest primary level 
leading to a detectable DPOAE. The ABRs in response to calibrated short tone bursts in the 
5-40 kHz range (repetition rate 17/s) were derived by the synchronous averaging of 
electroencephalograms recorded between subcutaneous stainless steel electrodes at the 
vertex and ipsilateral mastoid, with the help of a standard digital averaging system 
(CED1401+). A hundred responses to the tone bursts were averaged, except within 10 dB of 
the ABR threshold (defined as the smallest tone-burst level giving rise to at least one 
repeatable wave above background noise levels, 150 nV in an anesthetized animal), for 
which 300 tone bursts were used. Once ABR thresholds had been assessed, ABRs in 
response to 95 and 105 dB SPL tone bursts (100 averages) were collected for the analysis of 
suprathreshold ABR waveforms, amplitudes and latencies. Controlled sound-exposure was 
applied with the same acoustic probe used for ABRs, without moving the sound delivery 
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system, so that pre- and post-exposure ABRs shared the same calibration. The intense 
stimuli were the same tone bursts used for ABR measurements at 105 dB SPL, presented 
1000 times, at the same repetition rate of 17/s. 
The eighth cranial nerve was stimulated electrically with a silver electrode placed in the 
round-window niche and excited by biphasic electrical impulses (neutral electrode in neck 
muscles; peak amplitude of electrical stimulus about 0.5 V; duration of the positive and 
negative phases 150 µs; adjustable repetition rate). EEBRs were extracted with the same 
setup as for ABRs (Roux et al., 2006), in response to 100 electrical impulses presented with 
alternating polarities (repetition rate 17/s). The EEBR threshold was defined as the smallest 
electrical amplitude leading to repeatable waves above the level of background noise (the 
same as for ABRs), labeled from E II to E IV in reference to their ABR equivalents, II-IV 
(Henry, 1979). Controlled electrical stimulation was applied at 5 dB above the EEBR 
detection threshold, with a 200 Hz repetition rate. The silver electrode on the round window 
was occasionally also used to record compound action potentials (CAPs) in response to the 
same tone bursts used for ABR studies (means of 32 presentations, repetition rate 17/s), 
before EEBR data collection. These recordings were used to check that CAP thresholds and 
ABR thresholds were within 2 dB of each other at all frequencies, and the exact position of 
ABR wave I could be ascertained form the larger wave N1, its equivalent on CAP 
recordings. This was particularly important in mice with an abnormally small wave I, to 
prevent incorrect identifications (when wave I was reduced to a very small flattened 
deflection resembling a summating potential, the slightly larger wave II might have been 
erroneously labeled wave I on ABR recordings, whereas wave N1, even when small, 
retained its characteristic shape). 
The round-window electrode also provided access to the cochlear microphonic potential 
(CM), with the same setting used for CAP measurements, except that the stimulus polarity 
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was fixed for CM recordings, instead of alternating between rarefaction and condensation 
tone-bursts for CAP detection. CM is a far-field potential resulting from mechanoelectrical 
transduction currents through the OHCs at the basal end of the cochlea, near the collecting 
electrode, and is an oscillating change in electric potential at the stimulus frequency. 
Although its shape is closely similar to that of the stimulus that activates the sound-
delivering earphone, it was easily separated from a possible electric artefact radiated by the 
earphone by its delay of about 0.5 ms after stimulus onset, in relation to sound propagation 
along the tubing system that connected the earphone to the ear canal of the mouse. Its peak-
to-peak amplitude was measured for a stimulus of 5 kHz (a frequency much lower than the 
best frequency of the responding OHCs, so that CM was independent of their electromotility 
status) presented at 95 dB SPL.  
 
Controlled sound-exposure in DFNB59 patients 
We assessed the hypervulnerability to sound of patients, using the minimal sound-exposure 
leading to ABRs. ABRs were first recorded in response to 250 impulse stimuli (clicks, with 
a repetition rate of 20/s) at 99 dB above the normal detection threshold (the maximum level 
with this equipment, a Vivosonic IntegrityTM Version 4.50), 20-30 dB above the ABR 
threshold in the tested ear. The averaging was then extended to 500 and 1000 clicks, and 
wave identification, amplitudes and latencies post click onset were compared for the three 
averaged ABRs. In control patients, averaging was prolonged until about 4000 responses to 
clicks had been collected. After a 10-minute pause with no sound stimulus, the procedure 
was repeated. TEOAEs were averaged just before the first ABR procedure, then just after, in 
response to 260 series of clicks presented at 40 dB above the normal detection threshold 
(these clicks were therefore inaudible in patients).  
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Recording of mouse vocalizations  
The protocol was adapted from that described by Menuet et al. (2011). The mice were 
placed in a polyethylene cage covered with a metal wire lid. A free field microphone (type 
4192, ½-inch, Brüel & Kjaer) was placed 2 cm above the metal lid, in the center of the cage. 
The microphone output was preamplified (microphone power supply type 2801, Brüel & 
Kjaer) and digitized by a computer sound card (Dell D830; Dell Inc.) at a sampling rate of 
192 kHz. Acoustic vocalizations in the 5-90 kHz frequency range were stored online with 
Adobe Audition 1.5 software. They were analyzed with software developed in Matlab (The 
MathWorks Inc., MA) providing a spectrographic display of vocalizations in the time-
frequency domain, from which the total vocalization time, mean intensity of vocalizations, 
and spectral complexity of vocalizations were determined. 
 
Housing of mice in an acoustically quiet environment 
As most of the noise to which young mice are exposed is due to vocalizations (Ehret & 
Riecke, 2002), we split pups from the same litter into three groups, which were then placed 
in isolated boxes. The pups were separated before P10, corresponding to several days before 
hearing onset in mice. The boxes were kept in quiet booths, shielded from the sounds 
emanating from other cages. The cages of the first group contained two mice and a foster 
mother, those of the second group contained four mice and a foster mother, and those of the 
third group contained the remaining pups (6 to 10) and their mother. 
 
Determination of total and oxidized glutathione contents 
Total glutathione (GSH + GSSG) and oxidized glutathione (GSSG) levels were determined 
as described by Rahman et al. (2006). Total glutathione and GSSG levels were evaluated by 
spectrometry at 405 nm. GSH concentration was calculated by subtracting the concentration 
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of GSSG from the total glutathione concentration. Three independent experiments were 
performed, on the cochlea of P21 Pjvk+/+ and Pjvk-/- mice. 
 
Quantification of lipid peroxidation 
We determined the concentration of malondialdehyde, a by-product of lipid peroxidation, 
with the thiobarbituric acid-reactive substances assay kit (Cayman Chemical Company) and 
fluorometry at 590 nm. Three independent experiments were performed. For each assay, 
cochlear sensory epithelia were microdissected from 30 Pjvk+/+ and 30 Pjvk-/- mice. 
 
Plasmids and DNA transfection 
The full-length pejvakin cDNA was obtained by RT-PCR on a double-stranded cDNA 
library prepared from the organs of Corti of P7 C57BL/6 mice. It was inserted into the 
pIRES2-EGFP vector (Clontech). The mutant pejvakin clones (missense and frameshift 
mutations) were prepared from the wild-type pejvakin clone with the QuikChange™ Site-
Directed Mutagenesis kit (Stratagene). HeLa cells were transiently transfected using 
Lipofectamine™ 2000 (Invitrogen), according to the manufacturer’s instructions. 
 
Treatment of mouse embryonic fibroblasts with H2O2 
Fibroblasts were isolated from mouse embryos at embryonic day 13.5 and cultured as 
described by Xu (2005). The cells were incubated in DMEM (Gibco) supplemented with 0.1 
mM β-mercaptoethanol, and 0.5 mM H2O2 for 4 hours at 37 °C, under normoxic conditions 
(95% air). The culture medium was then replaced with H2O2-free medium. Cell viability was 
checked 18 hours after H2O2 treatment, by measuring mitochondrial reductase activity with 
the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (Sigma M2128) 
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assay. A polyclonal antibody against peroxisome membrane protein 70 (PMP70, Abcam 
ab3421) was used to label peroxisomes. 
 
AAV-Pjvk viral constructs and intracochlear viral transduction  
AAV2/8-Pjvk-IRES-EGFP was obtained by inserting the murine pejvakin cDNA flanked by 
an IRES-EGFP reporter cDNA sequence into the multiple cloning site of the 
pENN.AAV.CB7.CI.RBG vector (PennVector P1044, Penn Medicine Vector Core - 
University of Pennsylvania School of Medicine). The virus was produced and titrated by 
Penn Medicine Vector Core. AAV8-Pjvk was produced by inserting the murine pejvakin 
cDNA into a single-promoter Ad.MAX™ shuttle vector (ITR-CAG-Dfnb59-WPRE-PolyA-
ITR; SignaGen Laboratories). The virus was packaged and titrated by SignaGen 
Laboratories. 
Intracochlear viral transduction was carried out as described by Akil et al. (2012). A fixed 
volume (2 µl) of a solution containing AAV8-Pjvk or AAV2/8-Pjvk-IRES-EGFP 
recombinant viruses (1013 viral genomes/ml) was gently injected into the perilymphatic 
compartment of the cochlea through the round window. The pipette was withdrawn, the 
round window niche was quickly sealed with fascia and adipose tissue, and the bulla was 
sealed with adhesive tape (3M Vetbond).  
 
Anti-oxidant treatment 
All anti-oxidant drugs were purchased from Sigma. A dose of 1% N-acetyl-cysteine, or a 
cocktail of 0.75% α-lipoic acid, 0.5% α-tocopherol and 1% N-acetyl-cysteine, was added to 
the drinking water of Pjvk-/- mice during and after pregnancy, such that that the Pjvk-/- pups 
received the drug first in utero, and then via breast milk until P21. The auditory function of 
the pups, raised in groups of four pups per cage, was tested on P21. 
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Immunofluorescence studies 
For the detection of lipid oxidation products in the cochlea by immunohistofluorescence, 
inner ears were dissected in phosphate-buffered saline (PBS) and fixed by immersion in 4% 
paraformaldehyde (PFA) in PBS for 2 hours at 4°C. The samples were decalcified by 
incubation in 10% EDTA in PBS, pH 7.4, for 4 days at 4°C, fixed again in 4% PFA in PBS 
for 1 hour, rinsed twice in PBS for 10 minutes each, and immersed in 20% sucrose in PBS 
for 12 hours. They were embedded in Tissue Freezing Medium (Triangle Biomedical 
Sciences) and frozen. Cryostat sections (12 µm thick) were used for 
immunohistofluorescence, with an antibody against 4-hydroxy-2-nonenal (1:200, Abcam 
ab46545).  
For brainstem immunohistofluorescence analyses, P21 mice were killed by the injection of a 
lethal dose of ketamine chlorhydrate, and perfused intravascularly with PBS, followed by 
4% PFA in PBS. The brain was excised and fixed in 4% PFA in PBS for 1 hour at 4 °C. The 
fixed tissues were immersed in 20% sucrose at 4°C overnight, and then frozen in dry ice-
cooled isopentane at –30°C to –50°C. Cryostat sections (14 µm thick) were cut and used for 
immunohistofluorescence analyses. 
For whole-mount immunolabeling analyses, the inner ears were fixed in 4% PFA in PBS, 
and the cochlear sensory areas (organ of Corti) were microdissected. The tissues were rinsed 
twice in PBS, then permeabilized and blocked by incubation in PBS containing 20% normal 
goat serum and 0.3% Triton X-100 for 1 hour at room temperature. For GFP detection, 
whole-mount cochleas were incubated with a mixture of rabbit anti-GFP antibody (1:100, 
Invitrogen A11122) and chicken anti-GFP antibody (1:100, Abcam ab13970) in 1% bovine 
serum albumin (BSA) in PBS. A monoclonal antibody against parvalbumin (1:500, Sigma 
SAB4200545) was used to label auditory neurons. A polyclonal antibody against 
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peroxisome membrane protein 70 (PMP70, 1:100, Abcam ab3421) was used to label 
peroxisomes. Anti-myosin VI (Roux et al., 2009), anti-ribeye/CtBP2 (Santa Cruz sc-5966), 
and anti-glutamate receptor 2 (GluR2, Invitrogen 32-0300) antibodies were used to delimit 
the contours of IHCs, to label and count IHC ribbons, and to label post-synaptic glutamate 
receptors on the dendritic ends of cochlear ganglion neurons, respectively.  
For immunocytofluorescence analyses, HeLa and HepG2 cells were fixed by incubation in 
4% PFA in PBS for 15 minutes, washed in PBS, and incubated in 50 mM NH4Cl, 0.2% 
Triton X-100 solution for 15 minutes at room temperature. The cells were washed and 
incubated in 20% normal goat serum in PBS for 1 hour. Cells were incubated with the 
primary antibody in 1% BSA in PBS for 1 hour. Peroxisomes were labeled with an antibody 
against PMP70 (1:100, Abcam ab3421). An antibody against mitochondrial import receptor 
subunit TOMM22 (1:100, Sigma HPA003037) was used to label mitochondria. The mouse 
monoclonal antibody against pejvakin (Pjvk-G21) was used at 100 µg/ml to determine the 
subcellular distribution of pejvakin. Cells were then washed in PBS and incubated with the 
appropriate secondary antibody for 1 hour at room temperature. 
For immunofluorescence studies, we used Atto-488- or Atto-647-conjugated goat anti-rabbit 
IgG (1:500, Sigma 18772, 40839), Atto-550-conjugated goat anti-mouse IgG (1:500, Sigma 
43394), and Alexa-Fluor-488-conjugated goat anti-chicken IgG (1:500, Invitrogen A11039) 
as secondary antibodies. Atto-565 phalloidin (1:700, Sigma 94072) and DAPI (1:7500, 
Sigma D9542) were used to label actin and cell nuclei, respectively. Images were acquired 
with a Zeiss LSM700 Meta confocal microscope (Carl Zeiss MicroImaging, Inc.). 
Peroxisomes were counted automatically with the Particles Analysis plugin of ImageJ 
software (Collins, 2007). Enlarged peroxisomes were identified by measurements in two 
perpendicular directions, with ImageJ software.  
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Morphological analyses and peroxisome staining 
For scanning electron microscopy studies, mouse inner ears of P15 and P30 mice were fixed 
by perfusion of the perilymphatic compartment with 2.5% phosphate-buffered 
glutaraldehyde, and rinsed in PBS. Cochleas were then microdissected, dehydrated in graded 
ethanol solutions, and dried to critical point. Processed specimens were then mounted on 
aluminum stubs with colloidal silver adhesive, and sputter-coated with gold palladium 
before imaging in a JSM-6700 F Jeol scanning electron microscope. Inner ears from 10 
Pjvk+/+ mice (three at P15, four at P30, and three at P60), and 12 Pjvk-/- mice (three at P15, 
five at P30, and four at P60) were analyzed.  
For transmission electron microscopy studies, cochleas were prepared as previously 
described (Thelen et al., 2009). They were fixed by incubation in 2.5% glutaraldehyde in 0.1 
M Sörensen’s buffer, pH 7.4, for 2 hours at 4°C. After several washes in 0.1 M Sörensen’s 
buffer (pH 7.4), the samples were postfixed by incubation at 4°C with 2% osmium tetroxide 
in the same buffer for 1 hour. The selective staining of peroxisomes was carried out by a 
modified version of a published method (Angermüller & Fahimi, 1981). Briefly, the 
cochleas were fixed by incubation in 1% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2, 
at 4°C for 1 hour. After several washes in this buffer, the samples were immersed in 10 mM 
3,3’-diaminobenzidine (DAB) and 0.15% H2O2 in 0.05 M Teorell-Stenhagen buffer (57 
mM boric acid, 50 mM phosphoric acid, 35 mM citric acid, 345 mM NaOH), pH 10.5, for 
45 minutes at 30°C. After several washes in the same buffer, the samples were postfixed by 
incubation with 2% osmium tetroxide in H2O for 1 hour at 4°C. All the cochleas were then 
washed in deionized water, dehydrated in graded ethanol solutions, and embedded in Epon 
(Epon-812, Electron Microscopy Sciences) for 48 hours at 60°C. 
Ultrathin sections (70 nm thick) were obtained with an ultramicrotome (Reichert Ultracut E) 
equipped with a diamond knife (Diatome). The sections were mounted on copper grids 
 41 
coated with collodion. Sections for morphological analysis were contrast-stained with uranyl 
acetate and lead citrate, for 15 minutes each. The ultrathin sections were observed under a 
JEM-1400 transmission electron microscope (Jeol) at 80 kV, and photographed with an 11 
MegaPixel bottom-mounted TEM camera system (Quemesa, Olympus). The images were 
analyzed with iTEM software (Olympus). The quantitative data were obtained with the same 
software. 
 
Acoustic exposure for the quantification of cochlear transcripts and peroxisomes 
Three-week-old C57Bl/6 wild-type mice were used. In the first set of experiments, the 
animals were exposed to overstimulation for one hour with bandpass-filtered white noise, 
the spectrum of which covered the 5-20 kHz interval with an intensity of 105 dB SPL. Both 
transcripts and peroxisomes were quantified. In the second set of experiments, in which only 
transcripts were quantified, the mice were subjected to bandpass-filtered white noise with a 
spectrum covering the 5-20 kHz interval, but a lower intensity (90 dB SPL), for 1 hour. The 
white noise signal was generated with in-house Matlab software (The Mathworks), and was 
delivered by an amplifier to a set of four Ultrasonic Vifa speakers (Avisoft Bioacoustics). 
The speakers were attached to the tops of four custom-made, cylindrical sound-isolation 
chambers (15 cm in radius), in which the mice were enclosed. The noise intensity delivered 
by the speakers was calibrated with a BK4812 probe (Bruel & Kjaer) placed centrally on the 
lower surface of the isolation chambers. The sound field within each chamber varied by less 
than 10 dB over the lower surface. 
 
Microarray analysis and quantitative RT-PCR 
Total RNA was extracted from dissected organs of Corti of Pjvk-/- and wild-type  (Pjvk+/+) 
P15 mice in Trizol reagent (Invitrogen), purified on RNeasy columns (Qiagen), and tested 
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on an Agilent (Waldbronn) 2100 Bioanalyzer. Three biological replicates were run for each 
genotype. The cRNAs obtained from 100 ng of RNA were amplified with the GeneChip 
Expression Two-Cycle 3’ amplification system (Affymetrix). Fragmented biotin-labeled 
cRNA samples were hybridized to Affymetrix Mouse Gene ST 1.0 arrays. The array was 
then washed and stained according to the Affymetrix protocol. The stained array was 
scanned at 532 nm with an Affymetrix GeneChip Scanner 3000, producing CEL files. Gene 
expression levels were estimated from the CEL file probe-level hybridization intensities 
with the model-based Robust Multichip Average algorithm (Bolstad et al. 2003). Arrays 
were compared in local pool error tests (Jain et al., 2003), and the p values were adjusted 
with the Benjamini–Hochberg algorithm (Benjamini & Hochberg, 1995). The fold 
differences reflect the relative expression levels of the genes in the organs of Corti of Pjvk-/- 
mice normalized with respect to Pjvk+/+ mice.  
The differences in Mpv17, c-Dct, Gpx2, CypA, c-Fos, and Hsp70 transcript levels between 
sound-exposed and unexposed cochleas were analyzed by quantitative RT-PCR. For sound-
exposed mice, cochleas were collected at 1 hour, 3 hours, 6 hours, and 18 hours after sound-
exposure. RNA was extracted from dissected organs of Corti, with the NucleoSpin® RNA II 
kit (Macherey-Nagel). Quantitative RT-PCR was performed with the Universal Probe 
Library (UPL) system from Roche. UPL probes were labeled with a fluorescein derivative 
(FAM), and the fluorescence was read with the Applied Biosystems 7500 Real-Time PCR 
System. The thermocycling conditions were 50°C for 2 minutes, followed by 95°C for 2 
minutes, and then 40 cycles of 95°C for 15 s and 60°C for 30 s. Three independent 
experiments were performed for each sound-exposed or unexposed cochlea. Each assay was 
conducted for the target transcript probe-set in a multiplex reaction, in which the 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) probe set was used as an internal 
control. Relative levels of target transcripts were determined by the comparative cycle 
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threshold (CT) method. The relative copy number for each target transcript was calculated as 
2−ΔΔCT. The sequences of the primers and UPL probes are available on request. Transcription 
levels in the organ of Corti were compared, for each gene, between sound-exposed and 
unexposed mice, in unpaired Student’s t-tests. 
  
Measurements of synaptic exocytosis and IK,f (BK) current in IHCs, and of non-linear 
capacitance in OHCs  
Experiments were carried out on explants of the organ of Corti. The dissecting-steps were 
performed in a cold (5-10°C) perilymph-like solution containing (in mM): 135 NaCl, 5.8 
KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 NaH2PO4, 5.6 D-glucose, 2 Na pyruvate, and 10 Na-HEPES; 
pH 7.4 and osmolality near 300 mosmol/kg. The freshly dissected sensory organ was then 
mounted flat and continuously perfused at room temperature (22-24°C) in a perilymph-like 
solution. The sensory hair cells were viewed through a X40 LWD water immersion 
objective (NA = 0.8) on an Olympus BX51WI microscope. Whole-cell voltage clamp 
recordings were obtained using 3-4 MΩ  electrodes pulled from borosilicate glass capillaries 
(1B150F-4, WPI Sarasota Fl) on a Sachs-Flaming Microelectropuller (Model PC-84, Sutter 
Instrument Company). Acquisition was done using the Patchmaster	  software (HEKA). 
Ca2+ current and exocytosis recordings in IHCs were performed in the perilymph-like 
solution containing 5 mM Ca2+, and supplemented with 1 µM TTX (Sigma), 10 mM TEA-
Cl and 100 nM apamin (Latoxan). The internal pipette solution contained the following (in 
mM): 150 CsCl, 1 MgCl2, 5 TEA-Cl, 1 EGTA, 5 Na2ATP, 0.5 Na2GTP, 5 Cs-HEPES; pH 
7.4 and osmolality near 300 mosmol/kg. The liquid junction potential was about 2 mV and 
was not corrected in our Cm experiments. Real time changes in membrane capacitance (ΔCm) 
were measured using the “track-in” circuitry of the HEKA EPC 10 patch clamp amplifier, as 
previously described (Dulon et al., 2009). A 2.5 kHz sine wave of 15-20 mV was applied to 
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the cells from a holding potential of –80 mV. Cm signals were low-pass filtered at 80 Hz. 
ΔCm responses were measured 50 ms after the end of the depolarizing pulse, and averaged 
over a period of 100 to 300 ms. 
For IK,f (BK) current measurement in IHCs, explants were bathed in the perilymph-like 
solution. The internal solution was a 290 mOsm KCl-based internal solution containing (in 
mM): 135 KCl, 0.1 CaCl2, 1.5 MgCl2-6H2O, 11 EGTA, 5 HEPES, 2.5 Na2ATP; pH 7.4. 
Series resistance (Rs) compensation (50-65%; Rs = 6.34 ± 0.34 MΩ) was applied on line 
with the series resistance compensation circuitry of the amplifier throughout recordings. To 
construct the current-voltage curves, IK,f current amplitudes were measured at 1.3 ms after 
the start of voltage-pulse (from a holding potential of -80 mV) and at the end of the 
depolarization step. Paxilline, 4-aminopyridine, and XE991 (Tocris Bioscience), blockers of 
IK,f, IK,s, and IK,n currents, respectively, were added to the external solution when necessary. 
Nonlinear capacitance measurements in OHCs were performed as described previously 
(Santos-Sacchi et al., 1998b).  
 
Imaging of mitochondrial membrane potential in a hemicochlea preparation 
We used the hemicochlea preparation described by Dallos and coworkers (Teudt and 
Richter, 2007). Briefly, P17- P30 mice were lightly anaesthetized with isoflurane gas and 
decapitated. The cranium was cut in half along the median sagittal axis. The temporal bones 
were removed and fixed to the stage of a vibrating tissue cutter (Vibratome 3000) with 
cyanoacrilate glue. Cochleas were then cut in half along the mid modiolar plane with a 
microtome blade (R35 Feather, Osaka, Japan) under ice-cold modified perilymph (22.5 mM 
NaCl, 120 mM sodium gluconate, 3.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM 
HEPES, 5.5 mM glucose). The pH was adjusted to 7.3-7.4, and the solution was saturated 
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with 100 % O2. The upper half of the cochlea was discarded after cutting. Only the lower 
parts were used for experiments.  
For functional imaging of mitochondrial membrane potential (∆ψm), the hemicochleas were 
loaded with 5 µM rhodamine 123 (Rh123, Invitrogen) for 5 minutes at room temperature, 
then washed. When Rh123 is used in the quenched mode, mitochondrial depolarization 
produces a marked increase in the fluorescence, and ∆ψm changes can be followed reliably 
(Nicholls and Ward, 2000; Duchen et al., 2003). A perfusion of the protonophore carbonyl 
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, Sigma) at a concentration of 2 µM 
was used to trigger ∆ψm collapse. 
Hemicochleas were continuously perfused with modified perilymph in an experimental 
chamber. The perfusion velocity was 3.5 ml/minute, and the solution was 100 % saturated 
with O2. All experiments were performed at 36 ± 0.5 oC. Fluorescent images were obtained 
with an upright epifluorescent microscope (Olympus BX50WI) equipped with a 4x objective 
(Olympus XLFluor 4x/340 NA 0.28). With this set up, we were able to image the entire 
hemicochlea preparation. Oblique illumination was used for orientation purposes. Changes 
in ∆ψm were observed over the whole section of the cochlear ganglion and organ of Corti in 
the basal, middle and apical cochlear turns. Rh123 was excited at 495 ± 5 nm with a 
monochromator equipped with a xenon arc lamp (Polychrome II; T.I.L.L. Photonics 
GMBH). Emitted light was filtered by a 535/50 band-pass filter (Chroma Technology 
Corporation) and detected with a cooled CCD camera (Photometrics Quantix), at an image 
frame rate of 12 images/minute. Image intensities were background-corrected using a nearby 
area devoid of loaded cells. Axon Imaging Workbench 6 software (Axon Instruments) was 
used for image acquisition and detailed offline analysis. The data were further analyzed and 
plotted with Wavemetrics Igor Pro 6. The rise time of the evoked mitochondrial 
 46 
depolarization was determined as the time needed from the start of the response to 
maximum intensity. 
 
 
SUPPLEMENTAL FIGURE LEGENDS 
Figure S1. Strategy for the targeted replacement of the Pjvk wild-type allele with a 
floxed allele, Related to Figures 1 and 2. (A) Schematic diagram of the murine Pjvk gene 
and the targeting construct used to produce a floxed Pjvk allele (Pjvkfl) with loxP sequences 
(triangles) flanking exon 2, followed by a Pgk-neo cassette. DTA: diphtheria toxin A 
fragment. An additional SacI site (in bold) was engineered after the first loxP site, for 
Southern blot analysis. Small arrows indicate the positions of the PCR primers used to 
screen for clones of recombinant embryonic stem cells. Right panel: Southern blot analysis 
of SacI-digested genomic DNA from Pjvk+/+ (+/+) and Pjvkfl/+ (fl/+) mice. Exon 2 of Prkra 
(a gene flanking Pjvk, on the centromeric side) was used as the probe for Southern blot 
analysis. The probe hybridizes to a 4.6 kb fragment from the floxed allele and a 7.2 kb 
fragment from the wild-type allele. (B) RT-PCR analysis of the Pjvk transcript in the inner 
ears of P7 Pjvk+/+ and Pjvk-/- mice. Pjvk-/- mice were obtained by crossing Pjvkfl/fl mice with 
transgenic mice carrying the cre recombinase gene under the control of the ubiquitous PGK 
promoter. The expected 1059 bp amplicon was detected in the Pjvk+/+ mouse (lane 1), 
whereas a 963 bp fragment was detected in the Pjvk-/- mouse (lane 2), because of the 
deletion of exon 2. M, DNA size marker: ϕX174 DNA HaeIII digest. See also Figure S6B 
for validation of the Pjvk knockout (Pjvk-/-) and conditional knockout (Pjvkfl/flMyo15-cre+/-) 
mouse models at the protein level. 
 
Figure S2. Transduction of neurons in the auditory pathway and of cochlear hair cells 
with the AAV8 and AAV2/8 viral vectors, respectively, Related to Figures 2J-L and 
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7D-J. (A-B) AAV8-EGFP or AAV2/8-EGFP was injected into the cochleas of P3 mice, and 
transduced cells were detected at P21 by EGFP immunostaining (green) on cryosections of 
the cochlear ganglion (basal turn) (A, lower panel) and of the cochlear nucleus (A, upper 
panel), and whole-mount preparations of the organ of Corti from the cochlear middle turn 
(B). The block diagram shows the organ of Corti and the main ascending auditory pathway 
that projects both ipsilaterally and contralaterally (for the sake of clarity, we show 
projections from only one cochlea). AAV8-EGFP-transduced auditory neurons are identified 
by their parvalbumin (red) and EGFP (green) co-immunoreactivity (A). AAV2/8-EGFP 
transduces the vast majority of inner hair cells (IHCs) and a smaller proportion of outer hair 
cells (OHCs). The numbers on the DAPI-stained cell nuclei indicate the three rows of OHCs 
(B). Scale bars are 50 µm in (A) and 10 µm in (B). 
 
Figure S3. Degeneration of the organ of Corti with lipid peroxidation in Pjvk-/- mice, 
Related to Figure 4A. (A) Progressive degeneration of the organ of Corti in Pjvk-/- mice. 
Upper panels: Scanning electron micrographs showing surface views of the organ of Corti in 
the basal turn of the cochlea from P60 Pjvk+/+ and Pjvk-/- mice. In the Pjvk-/- mouse, many 
outer hair cells (OHCs), inner hair cells (IHCs), and pillar cells (PCs) are missing. Scale bars 
are 5 µm. Lower panels: Light micrographs of cross sections taken from the middle turn of 
the cochlea in Pjvk+/+ and Pjvk-/- mice on P90. In the Pjvk-/- mouse, OHCs, IHCs, and 
supporting cells can’t be identified anymore, and the organ of Corti has degenerated (arrow). 
In addition, the numbers of nerve fibers and cochlear ganglion neurons (arrowheads) are 
markedly decreased. Scale bars are 80 µm. (B) Increased lipid peroxidation in the cochlea of 
Pjvk-/- mice. Cryosections of the organ of Corti (middle turn, upper panels) and of the 
cochlear ganglion (apical and basal turns, lower panels) from P60 Pjvk+/+ and Pjvk-/- mice, 
immunolabeled for 4-HNE, a by-product of lipid peroxidation (green), and stained with 
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DAPI (blue) to show cell nuclei. Asterisks indicate the nuclei of OHCs and IHCs. In the 
Pjvk-/- mouse, some OHCs and cochlear ganglion neurons are missing, but the OHCs present 
are highly immunoreactive for 4-HNE (arrows), as are the cochlear ganglion neurons, 
especially in the basal turn. Scale bars are 20 µm. 
 
Figure S4. Expression levels of genes in Pjvk-/- mice and in response to loud sounds in 
Pjvk+/+ mice, Related to Figure 6. (A) Quantitative RT-PCR in Pjvk-/- mice to confirm 
microarray results for the genes involved in redox balance. "Fold change" denotes the level 
of expression of the gene in the organ of Corti of Pjvk-/- mice relative to that in Pjvk+/+ mice, 
with the minus sign indicating downregulation. All four genes tested, c-Dct, Mpv17, CypA, 
and Gpx2, were less strongly expressed in the organ of Corti of P15 Pjvk-/- mice than in 
Pjvk+/+ mice, in both microarray (transcriptome) and quantitative RT-PCR (qRT-PCR) 
analyses. (B) Effect of exposure of wild-type (Pjvk+/+) mice to loud sound on the expression 
of Pjvk and other anti-oxidant genes in the organ of Corti. Relative levels (fold change) of 
Pjvk, c-Dct, CypA, c-Fos, and HSP70 transcripts, as measured by quantitative RT-PCR in 
the organ of Corti of sound-exposed (5-20 kHz, 90 dB for 1 hour) P21 wild-type (Pjvk+/+) 
mice after 6 hours in a silent environment versus levels in unexposed mice. Sound-exposure 
leads to a marked increase in the levels of Pjvk and CypA transcripts (3.0 ± 0.3-fold and 4.0 
± 1.0-fold, respectively), but only a moderate (less than 2-fold) increase in the levels of c-
Dct, Hsp70, and c-Fos transcripts. This indicates that Pjvk and CypA are involved in the 
early cochlear response to noise. Error bars indicate the SEM.  
 
Figure S5. Cochlear physiological characteristics in Pjvk-/- mice, Related to Figure 4.  
(A) Normal number of ribbon synapses and Ca2+-dependent synaptic exocytosis in Pjvk-/- 
inner hair cells (IHCs). Upper panel: The synapses between IHCs and the primary auditory 
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neurons were double-immunolabeled for the presynaptic marker ribeye that labels IHC 
ribbons (green), and the postsynaptic glutamate receptor GluR2 (red). The bar chart shows 
the quantitative analysis of ribbon synapses from Pjvk+/+ (blue) and Pjvk-/- (red) mice on P20.  
N: cell nucleus of IHC. Lower panel: Synaptic function. Left: Bar chart representation of the 
peak of ICa and of the increase in membrane capacitance (ΔCm) in response to a 100 ms 
voltage step from -80 mV to -10 mV in P20 Pjvk+/+ (blue) and Pjvk-/- (red) IHCs. ICa and 
ΔCm values were similar in Pjvk-/- IHCs (126 ± 16 pA and 21.3 ± 2.2 fF, n = 6) and Pjvk+/+ 
IHCs (110 ± 16 pA and 20.0 ± 2.0 fF, n = 5; t-test, p = 0.47 and p = 0.64) for ICa and ΔCm 
comparison, respectively. Middle: Synaptic transfer function describing the relation between 
ΔCm and ICa in P20 Pjvk+/+ (n = 3; blue dots) and Pjvk-/- (n = 3; red dots) IHCs. Cells were 
stimulated by a constant 100 ms voltage step at various membrane potentials from -80 mV 
to -5 mV.  Fits to single data points were done by using a simple power function with N = 
0.70 ± 0.10 and N = 0.63 ± 0.10 in Pjvk-/- and Pjvk+/+ IHCs, respectively. The mean slope, 
representing Ca2+ efficiency, was 0.17 ± 0.05 and 0.15 ± 0.02 fF/pA in Pjvk-/- IHCs and 
Pjvk+/+ IHCs, respectively (t-test, p = 0.73). Right: Increase in membrane capacitance (ΔCm) 
produced by a train of 20 successive 100 ms voltage steps from -80 to -10 mV, separated by 
100 ms time intervals, in P20 Pjvk+/+ (n = 3; blue dots) and Pjvk-/- (n = 3; red dots) IHCs. 
Pjvk-/- and Pjvk+/+ IHCs display similar linear increase in membrane capacitance (mean slope 
of 5.14 ± 0.10 and 5.04 ± 0.35 fF/stimulus in Pjvk-/- and Pjvk+/+ mice, respectively; t-test, p = 
0.76). (B) Most Pjvk-/- inner hair cells (IHCs) lack the fast voltage-activated IK,f current. IK,f, 
IK,s, and IK,n are the main K+ currents found in mature IHCs. Upper left: Example traces for 
potassium currents (IK,f + IK,s) recorded for a voltage step to -10 mV from a holding potential 
of -80 mV, in a P19 Pjvk+/+ (blue) and two P19 Pjvk-/- (red) IHCs. Enlarged time scale of the 
current onset, on the right, shows the fast voltage-activated outward current, IK,f, in the 
control IHC and one Pjvk-/- IHC, whereas in the other Pjvk-/- IHC, only a slow current can be 
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observed. Upper middle: Current-voltage (I-V) curves representing mean amplitudes of IK,f  
(measured 1.3 ms after the onset of the depolarizing pulse, a time point at which IK,s is not 
yet activated) and of the steady-state current (IK,f + IK,s, measured at the end of the voltage 
step) as a function of the membrane potential (Vm). For Pjvk-/- IHCs, two cell groups were 
defined, based on the presence (open circles) or absence (closed circles) of IK,f. Upper right: 
bar charts showing the mean amplitudes of the IK,f and IK,f + IK,s currents obtained in 
response to a voltage-step from -80 to -10 mV. IK,f was detected in all 7 IHCs from Pjvk+/+ 
mice, but in only four of the 11 IHCs from Pjvk-/- mice. The current-voltage relationship at 
1.3 ms did not display significantly different conductances in Pjvk+/+ IHCs (160 ± 20 nS, n = 
7) and in the few Pjvk-/- IHCs showing IK,f (129 ± 25 nS, n = 4 out of 11), with a mean IK,f 
amplitude at -10 mV of 1.2 ± 0.2 nA and 0.9 ± 0.3 nA, respectively (p = 0.53 for both 
conductance and amplitude comparisons). Lower left: IK,f blockade with paxilline (10 µM), a 
selective BK channel blocker, in Pjvk+/+ and Pjvk-/- IHCs submitted to a voltage step from -
80 to -10 mV. No current reduction in the presence of paxilline (both at 1.3 ms and steady 
state plateau) was observed in the Pjvk-/- IHCs that displayed only the slow outward current 
component IK,s, indicating that these cells indeed do not have functional BK channels. The 
amplitudes of IK,s were similar in Pjvk+/+ and Pjvk-/- IHCs (1.76 ± 0.41 nA vs. 1.65 ± 0.24 
nA at -10 mV; t-test,  p = 0.6). Lower middle: Traces representing potassium currents (IK,f + 
IK,s + IK,n) in an IHC from a P19 Pjvk-/- mouse. Lower right: Bar chart showing the mean 
amplitudes of IK,n measured at -120 mV in  IHCs from P19 Pjvk-/- and Pjvk+/+ mice. Inward 
IK,n currents, sensitive to XE991 (30 µM; data not shown), were recorded in all P19-P24 
Pjvk+/+ and Pjvk-/- IHCs in response to hyperpolarizing voltage steps from -80 mV to -120 
mV, and their amplitudes were similar in the two groups (0.93 ± 0.13 nA vs. 1.3 ± 0.28 nA, 
respectively; n = 6 in both groups; t-test, p = 0.3). Together, these results indicate that Pjvk-/- 
IHCs display normal IK,s and IK,n currents, but most of the cells (64 % of the Pjvk-/- IHCs 
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tested) lack the IK,f (BK) current. (C) Impaired electromotility of Pjvk-/- OHCs. Left panel: 
Non-linear capacitance (Cm) of 10 Pjvk+/+ and 16 Pjvk-/- OHCs, as a function of the 
membrane potential (Vm). Smooth lines are fits based on a two-state Boltzmann function 
(implemented in JClamp) with values of Qmax, V1/2, z, and Clinear of 1.1 ± 0.9 pC, -33.6 ± 3.5 
mV, 0.75 ± 0.05, and 6.6 ± 0.2 pF for Pjvk+/+ OHCs, and 0.83 ± 0.37 pC, -30.5 ± 1.3 mV, 
0.85 ± 0.03, and 7 ± 0.3 pF for Pjvk-/- OHCs, respectively. Right panel: Bar chart showing a 
30% mean decrease of maximal charge density (Q’ = Q/Clinear) in Pjvk-/- OHCs. (D) 
Dissipation of the ∆ψm revealed no difference in mitochondrial status between Pjvk+/+ and 
Pjvk-/- cochleas. Functional imaging of ∆ψm was performed over sections of the organ of 
Corti and cochlear ganglion, in turns of the hemicochlea of P17-P30 Pjvk+/+ and Pjvk-/- mice 
(n = 12 ears for each genotype), after loading the preparation by Rh123. A perfusion of the 
protonophore FCCP was used to trigger ∆ψm collapse. The starting latencies (SL) of the 
response and rise times (RT) of the evoked depolarization peaks were calculated and 
compared. The inset graphs demonstrate the way of determination of SL and RT on a 
representative trace. In the bar charts, basal, middle, and apical denote cochlear turns. The 
six regions of interest are delimited by black borders on the insets showing the fluorescent 
and obliquely illuminated images of a hemicochlea. 
Error bars represent the SD in (A-C), and the SEM in (D). n.s., not significant, *** p < 
0.001. 
 
Figure S6. Pejvakin immunostaining of peroxisomes, Related to Figure 5. (A) Pejvakin 
is associated with peroxisomes in transfected HeLa cells. Transfected HeLa cells producing 
pejvakin (Pjvk-EGFP, upper panel) and untransfected cells (lower panel) were 
immunostained with both an anti-pejvakin antibody (Pjvk-G21) and an antibody against 
peroxisome membrane protein 70 (PMP70). Cell nuclei were stained with DAPI (blue). 
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Colocalization of the immunostainings of pejvakin (red) and PMP70 (green) was observed 
in transfected cells (see inset for higher magnification of the boxed area). Pejvakin was not 
detected in untransfected cells. (B) Absence of immunolabeling in inner hair cells (IHCs) 
from P21 Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice with the Pjvk-G21 antibody demonstrates the 
specificity of this antibody (see Figure 5B for immunolabeling in Pjvk+/+ IHCs). (C) 
Pejvakin immunostaining of dividing peroxisomes. Double immunolabeling of HepG2 cells 
for pejvakin (red) and PMP70 (green). Upper panel: arrowheads indicate pejvakin-
immunoreactive protrusions from pre-existing peroxisomes. Lower panel: boxed areas show 
pejvakin-immunoreactive string-of-beads structures corresponding to elongated and 
constricted peroxisomes (preceding final fission). Scale bar is 10 µm in (A), 5 µm in (B), 
and 2 µm in (C). 
 
Figure S7. Pejvakin-dependent peroxisomal proliferation, Related to Figure 5. (A) 
Proliferation of peroxisomes induced by H2O2 in Pjvk+/+ mouse embryonic fibroblasts. F-
actin (red), PMP70 (green), and DAPI (blue) staining of Pjvk+/+ (left panel) and Pjvk-/- (right 
panel) mouse embryonic fibroblasts (MEFs), treated with 0.5 mM H2O2 for 4 hours or left 
untreated, and analyzed 18 hours later. H2O2-treatment increases the number of peroxisomes 
only in the Pjvk+/+ cells (see quantification in Figure 5C). (B) Larger numbers and 
enlargement of peroxisomes in transfected HeLa cells producing wild-type and mutant 
forms of pejvakin, respectively. In cells producing EGFP alone, EGFP and wild-type 
pejvakin (Pjvk), or EGFP and the p.T54I, p.R183W, p.C343S, or p.V330Lfs*7 mutated 
forms of pejvakin, peroxisomes were identified on the basis of their PMP70-
immunoreactivity. The upper panel shows F-actin (red), DAPI (dark blue), EGFP (green), 
and PMP70 (light blue) staining, whereas the lower panel shows only the PMP70 
immunostaining of individual cells delimited by a white border. The number of peroxisomes 
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is larger in cells producing wild-type pejvakin, and smaller in the cells producing any of the 
mutated forms of pejvakin, than in cells producing EGFP alone (see quantification in Figure 
5D). In addition, cells producing the mutated forms of pejvakin contain enlarged 
peroxisomes (arrowheads, and see insets for magnification; see also quantification in Figure 
5D). Scale bar is 20 µm in (A) and 10 µm in (B). 
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Table S1. Transcriptional changes in the organ of Corti of Pjvk-/- mice, Related to Figure 6A. 
 
 
Gene (encoded protein) 
Accession  
number 
Fold 
change 
Adjusted 
p-value 
Probe set  References 
Genes involved in ROS metabolism      
Mpv17 (Mpv17, mitochondrial inner membrane protein)  NM_008622 -3.40 3.34E-22 10529091  Binder et al, 1999; Meyer zum Gottesberge, 2001; 
Spinazzola et al., 2006 
c-Dct (c-Dopachrome tautomerase) NM_010024 -3.28 9.95E-50 10422249 Michard et al., 2008a; Michard et al., 2008b 
CypA (Cyclophilin A) NM_008907 -2.15 1.78E-09 10545337 Lee et al., 2001; Ge et al., 2009 
Gpx2 (Glutathione peroxidase 2) NM_030677 -1.59 4.87E-11 10401109 Evans and Halliwell, 1999 
Genes with modified expression in tumors      
Tax1bp3 (Tax1 (human T-cell leukemia virus type I) binding protein 3) NM_029564 -2.88 2.16E-15 10378334 Kanamori et al., 2003 
Plunc (Palate, lung, and nasal epithelium associated protein) NM_011126 2.20 6.89E-10 10477475 Bingle et al., 2005; He et al., 2005; Benlloch et al., 
2009 
Cd59a (CD59a antigen) NM_001111060 -2.13 1.78E-30 10474229 Madjd et al., 2003; Watson et al., 2006 
Pramel3 (Preferentially expressed antigen in melanoma-like 3) NM_031390 -1.94 6.05E-04 10601790 Schenk et al., 2007 
Lrp1b (Low density lipoprotein-related protein 1b) NM_053011 1.82 3.21E-07 10482336 Sonoda et al., 2004; Nakagawa et al., 2006; Lu et al., 
2010 
Genes encoding putative cell growth inhibitors      
Ifi44 (Interferon-induced protein 44) NM_133871 -2.20 3.45E-12 10502791 Hallen et al., 2007;  Kim et al., 2009 
Ifit3 (Interferon-induced protein with tetratricopeptide repeats 3) NM_010501 -2.08 2.72E-10 10462618 
Ifit1 (Interferon-induced protein with tetratricopeptide repeats 1) NM_008331 -1.75 1.53E-07 10462623 
Ifitm3 (Interferon-induced transmembrane protein 3) NM_025378 -1.60 1.42E-11 10569017 
Genes encoding ribosomal proteins      
Rps13 (Ribosomal protein S13) NM_026533 2.04 5.61E-08 10565434 Wool, 1996; Lai and Xu, 2007 
Rps23 (Ribosomal protein S23) NM_024175 -1.92 1.06E-08 10491730  
Rpl36 (Ribosomal protein L36) BC086914 -1.74 2.57E-04 10394609  
Gene involved in ubiquitin proteolytic pathway      
UbB (Ubiquitin B) NM_011664 -1.64 2.93E-07 10376864 Fischer et al., 2003; de Pril et al., 2010 
Gene encoding a synaptic protein      
a39-Takusan (Alpha39-takusan) EF651836 2.30 1.39E-07 10417411 Tu et al., 2007 
Fold change reflects the expression level of the gene in the organ of Corti of Pjvk-/- relative to Pjvk+/+ mice. + and - denote up-regulation and down-regulation, respectively. The p values  
were adjusted using the Benjamini-Hochberg algorithm. 
 














